ENTRY       hsa04014                    Pathway
NAME        Ras signaling pathway - Homo sapiens (human)
DESCRIPTION The Ras proteins are GTPases that function as molecular switches for signaling pathways regulating cell proliferation, survival, growth, migration, differentiation or cytoskeletal dynamism. Ras proteins transduce signals from extracellular growth factors by cycling between inactive GDP-bound and active GTP-bound states. The exchange of GTP for GDP on RAS is regulated by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs). Activated RAS (RAS-GTP) regulates multiple cellular functions through effectors including Raf, phosphatidylinositol 3-kinase (PI3K) and Ral guanine nucleotide-dissociation stimulator (RALGDS).
CLASS       Environmental Information Processing; Signal transduction
PATHWAY_MAP hsa04014  Ras signaling pathway
DISEASE     H01437  Neurofibromatosis type 1
DRUG        D10465  Golvatinib tartrate (USAN)
DBLINKS     GO: 0032318
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        1950  EGF; epidermal growth factor [KO:K04357]
            2246  FGF1; fibroblast growth factor 1 [KO:K18496]
            2247  FGF2; fibroblast growth factor 2 [KO:K18497]
            2248  FGF3; fibroblast growth factor 3 [KO:K04358]
            2249  FGF4; fibroblast growth factor 4 [KO:K04358]
            8822  FGF17; fibroblast growth factor 17 [KO:K04358]
            2251  FGF6; fibroblast growth factor 6 [KO:K04358]
            2252  FGF7; fibroblast growth factor 7 [KO:K04358]
            2253  FGF8; fibroblast growth factor 8 [KO:K04358]
            2254  FGF9; fibroblast growth factor 9 [KO:K04358]
            2255  FGF10; fibroblast growth factor 10 [KO:K04358]
            2256  FGF11; fibroblast growth factor 11 [KO:K04358]
            2257  FGF12; fibroblast growth factor 12 [KO:K04358]
            2258  FGF13; fibroblast growth factor 13 [KO:K04358]
            2259  FGF14; fibroblast growth factor 14 [KO:K04358]
            8823  FGF16; fibroblast growth factor 16 [KO:K04358]
            2250  FGF5; fibroblast growth factor 5 [KO:K04358]
            8817  FGF18; fibroblast growth factor 18 [KO:K04358]
            9965  FGF19; fibroblast growth factor 19 [KO:K04358]
            26281  FGF20; fibroblast growth factor 20 [KO:K04358]
            26291  FGF21; fibroblast growth factor 21 [KO:K04358]
            27006  FGF22; fibroblast growth factor 22 [KO:K04358]
            8074  FGF23; fibroblast growth factor 23 [KO:K04358]
            4803  NGF; nerve growth factor [KO:K02582]
            3630  INS; insulin [KO:K04526]
            3479  IGF1; insulin like growth factor 1 [KO:K05459]
            5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]
            5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]
            56034  PDGFC; platelet derived growth factor C [KO:K05450]
            80310  PDGFD; platelet derived growth factor D [KO:K05450]
            1435  CSF1; colony stimulating factor 1 [KO:K05453]
            4254  KITLG; KIT ligand [KO:K05461]
            7422  VEGFA; vascular endothelial growth factor A [KO:K05448]
            7423  VEGFB; vascular endothelial growth factor B [KO:K16858]
            5228  PGF; placental growth factor [KO:K16859]
            7424  VEGFC; vascular endothelial growth factor C [KO:K05449]
            2277  FIGF; c-fos induced growth factor (vascular endothelial growth factor D) [KO:K05449]
            3082  HGF; hepatocyte growth factor [KO:K05460]
            284  ANGPT1; angiopoietin 1 [KO:K05465]
            285  ANGPT2; angiopoietin 2 [KO:K05466]
            51378  ANGPT4; angiopoietin 4 [KO:K05467]
            1942  EFNA1; ephrin-A1 [KO:K05462]
            1943  EFNA2; ephrin-A2 [KO:K05462]
            1944  EFNA3; ephrin-A3 [KO:K05462]
            1945  EFNA4; ephrin-A4 [KO:K05462]
            1946  EFNA5; ephrin-A5 [KO:K05462]
            1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
            2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]
            2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]
            2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]
            2264  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]
            4804  NGFR; nerve growth factor receptor [KO:K02583]
            3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]
            3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]
            5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
            5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]
            1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]
            3815  KIT; KIT proto-oncogene receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]
            2321  FLT1; fms related tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]
            2324  FLT4; fms related tyrosine kinase 4 [KO:K05097] [EC:2.7.10.1]
            3791  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]
            4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]
            7010  TEK; TEK receptor tyrosine kinase [KO:K05121] [EC:2.7.10.1]
            1969  EPHA2; EPH receptor A2 [KO:K05103] [EC:2.7.10.1]
            2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]
            2549  GAB1; GRB2 associated binding protein 1 [KO:K09593]
            9846  GAB2; GRB2 associated binding protein 2 [KO:K08091]
            6464  SHC1; SHC (Src homology 2 domain containing) transforming protein 1 [KO:K06279]
            25759  SHC2; SHC (Src homology 2 domain containing) transforming protein 2 [KO:K17447]
            53358  SHC3; SHC (Src homology 2 domain containing) transforming protein 3 [KO:K17448]
            399694  SHC4; SHC (Src homology 2 domain containing) family member 4 [KO:K17449]
            5781  PTPN11; protein tyrosine phosphatase, non-receptor type 11 [KO:K07293] [EC:3.1.3.48]
            6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
            6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
            5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]
            5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]
            10125  RASGRP1; RAS guanyl releasing protein 1 [KO:K04350]
            10235  RASGRP2; RAS guanyl releasing protein 2 [KO:K12361]
            25780  RASGRP3; RAS guanyl releasing protein 3 [KO:K12362]
            115727  RASGRP4; RAS guanyl releasing protein 4 [KO:K12363]
            7535  ZAP70; zeta chain of T cell receptor associated protein kinase 70kDa [KO:K07360] [EC:2.7.10.2]
            27040  LAT; linker for activation of T-cells [KO:K07362]
            3363  HTR7; 5-hydroxytryptamine receptor 7 [KO:K04163]
            2782  GNB1; G protein subunit beta 1 [KO:K04536]
            2783  GNB2; G protein subunit beta 2 [KO:K04537]
            2784  GNB3; G protein subunit beta 3 [KO:K07825]
            59345  GNB4; G protein subunit beta 4 [KO:K04538]
            10681  GNB5; G protein subunit beta 5 [KO:K04539]
            54331  GNG2; G protein subunit gamma 2 [KO:K07826]
            2785  GNG3; G protein subunit gamma 3 [KO:K04540]
            2786  GNG4; G protein subunit gamma 4 [KO:K04541]
            2787  GNG5; G protein subunit gamma 5 [KO:K04542]
            2788  GNG7; G protein subunit gamma 7 [KO:K04543]
            94235  GNG8; G protein subunit gamma 8 [KO:K04544]
            2790  GNG10; G protein subunit gamma 10 [KO:K04545]
            2791  GNG11; G protein subunit gamma 11 [KO:K04546]
            55970  GNG12; G protein subunit gamma 12 [KO:K04347]
            51764  GNG13; G protein subunit gamma 13 [KO:K04547]
            2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]
            2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]
            5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
            5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
            5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
            5923  RASGRF1; Ras protein specific guanine nucleotide releasing factor 1 [KO:K04349]
            5924  RASGRF2; Ras protein specific guanine nucleotide releasing factor 2 [KO:K12326]
            2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]
            2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]
            2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]
            810  CALML3; calmodulin like 3 [KO:K02183]
            805  CALM2; calmodulin 2 (phosphorylase kinase, delta) [KO:K02183]
            808  CALM3; calmodulin 3 (phosphorylase kinase, delta) [KO:K02183]
            801  CALM1; calmodulin 1 (phosphorylase kinase, delta) [KO:K02183]
            163688  CALML6; calmodulin like 6 [KO:K02183]
            51806  CALML5; calmodulin like 5 [KO:K02183]
            3265  HRAS; Harvey rat sarcoma viral oncogene homolog [KO:K02833]
            3845  KRAS; Kirsten rat sarcoma viral oncogene homolog [KO:K07827]
            4893  NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog [KO:K07828]
            22808  MRAS; muscle RAS oncogene homolog [KO:K07831]
            6237  RRAS; related RAS viral (r-ras) oncogene homolog [KO:K07829]
            22800  RRAS2; related RAS viral (r-ras) oncogene homolog 2 [KO:K07830]
            4763  NF1; neurofibromin 1 [KO:K08052]
            5921  RASA1; RAS p21 protein activator 1 [KO:K04352]
            5922  RASA2; RAS p21 protein activator 2 [KO:K08053]
            22821  RASA3; RAS p21 protein activator 3 [KO:K12380]
            10156  RASA4; RAS p21 protein activator 4 [KO:K17630]
            100271927  RASA4B; RAS p21 protein activator 4B [KO:K17630]
            8831  SYNGAP1; synaptic Ras GTPase activating protein 1 [KO:K17631]
            8437  RASAL1; RAS protein activator like 1 [KO:K17632]
            9462  RASAL2; RAS protein activator like 2 [KO:K17633]
            64926  RASAL3; RAS protein activator like 3 [KO:K17634]
            11186  RASSF1; Ras association domain family member 1 [KO:K09850]
            83593  RASSF5; Ras association domain family member 5 [KO:K08015]
            6789  STK4; serine/threonine kinase 4 [KO:K04411]
            7074  TIAM1; T-cell lymphoma invasion and metastasis 1 [KO:K05731]
            5879  RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [KO:K04392]
            5880  RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) [KO:K07860]
            5881  RAC3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) [KO:K07861]
            5058  PAK1; p21 protein (Cdc42/Rac)-activated kinase 1 [KO:K04409] [EC:2.7.11.1]
            5062  PAK2; p21 protein (Cdc42/Rac)-activated kinase 2 [KO:K04410] [EC:2.7.11.1]
            5063  PAK3; p21 protein (Cdc42/Rac)-activated kinase 3 [KO:K05733] [EC:2.7.11.1]
            10298  PAK4; p21 protein (Cdc42/Rac)-activated kinase 4 [KO:K05734] [EC:2.7.11.1]
            56924  PAK6; p21 protein (Cdc42/Rac)-activated kinase 6 [KO:K05735] [EC:2.7.11.1]
            57144  PAK7; p21 protein (Cdc42/Rac)-activated kinase 7 [KO:K05736] [EC:2.7.11.1]
            387  RHOA; ras homolog family member A [KO:K04513]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            207  AKT1; v-akt murine thymoma viral oncogene homolog 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; v-akt murine thymoma viral oncogene homolog 2 [KO:K04456] [EC:2.7.11.1]
            10000  AKT3; v-akt murine thymoma viral oncogene homolog 3 [KO:K04456] [EC:2.7.11.1]
            8517  IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma [KO:K07210]
            1147  CHUK; conserved helix-loop-helix ubiquitous kinase [KO:K04467] [EC:2.7.11.10]
            3551  IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta [KO:K07209] [EC:2.7.11.10]
            4790  NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [KO:K02580]
            5970  RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A [KO:K04735]
            572  BAD; BCL2 associated agonist of cell death [KO:K02158]
            598  BCL2L1; BCL2 like 1 [KO:K04570]
            4303  FOXO4; forkhead box O4 [KO:K12358]
            356  FASLG; Fas ligand [KO:K04389]
            4301  MLLT4; myeloid/lymphoid or mixed-lineage leukemia [KO:K05702]
            8036  SHOC2; SHOC2 leucine-rich repeat scaffold protein [KO:K19613]
            5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
            5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            51365  PLA1A; phospholipase A1 member A [KO:K13618] [EC:3.1.1.-]
            8399  PLA2G10; phospholipase A2 group X [KO:K01047] [EC:3.1.1.4]
            26279  PLA2G2D; phospholipase A2 group IID [KO:K01047] [EC:3.1.1.4]
            30814  PLA2G2E; phospholipase A2 group IIE [KO:K01047] [EC:3.1.1.4]
            50487  PLA2G3; phospholipase A2 group III [KO:K01047] [EC:3.1.1.4]
            64600  PLA2G2F; phospholipase A2 group IIF [KO:K01047] [EC:3.1.1.4]
            81579  PLA2G12A; phospholipase A2 group XIIA [KO:K01047] [EC:3.1.1.4]
            84647  PLA2G12B; phospholipase A2 group XIIB [KO:K01047] [EC:3.1.1.4]
            5319  PLA2G1B; phospholipase A2 group IB [KO:K01047] [EC:3.1.1.4]
            5322  PLA2G5; phospholipase A2 group V [KO:K01047] [EC:3.1.1.4]
            5320  PLA2G2A; phospholipase A2 group IIA [KO:K01047] [EC:3.1.1.4]
            391013  PLA2G2C; phospholipase A2 group IIC [KO:K01047] [EC:3.1.1.4]
            123745  PLA2G4E; phospholipase A2 group IVE [KO:K16342] [EC:3.1.1.4]
            5321  PLA2G4A; phospholipase A2 group IVA [KO:K16342] [EC:3.1.1.4]
            8681  JMJD7-PLA2G4B; JMJD7-PLA2G4B readthrough [KO:K16342] [EC:3.1.1.4]
            100137049  PLA2G4B; phospholipase A2 group IVB [KO:K16342] [EC:3.1.1.4]
            8605  PLA2G4C; phospholipase A2 group IVC [KO:K16342] [EC:3.1.1.4]
            283748  PLA2G4D; phospholipase A2 group IVD [KO:K16342] [EC:3.1.1.4]
            255189  PLA2G4F; phospholipase A2 group IVF [KO:K16342] [EC:3.1.1.4]
            8398  PLA2G6; phospholipase A2 group VI [KO:K16343] [EC:3.1.1.4]
            11145  PLA2G16; phospholipase A2 group XVI [KO:K16817] [EC:3.1.1.4 3.1.1.32]
            2002  ELK1; ELK1, ETS transcription factor [KO:K04375]
            2113  ETS1; ETS proto-oncogene 1, transcription factor [KO:K02678]
            2114  ETS2; ETS proto-oncogene 2, transcription factor [KO:K02678]
            8315  BRAP; BRCA1 associated protein [KO:K10632] [EC:2.3.2.27]
            8844  KSR1; kinase suppressor of ras 1 [KO:K14958]
            283455  KSR2; kinase suppressor of ras 2 [KO:K18529] [EC:2.7.11.1]
            9771  RAPGEF5; Rap guanine nucleotide exchange factor 5 [KO:K08019]
            5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]
            5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]
            5900  RALGDS; ral guanine nucleotide dissociation stimulator [KO:K08732]
            23179  RGL1; ral guanine nucleotide dissociation stimulator like 1 [KO:K17635]
            5863  RGL2; ral guanine nucleotide dissociation stimulator like 2 [KO:K17636]
            5898  RALA; v-ral simian leukemia viral oncogene homolog A (ras related) [KO:K07834]
            5899  RALB; v-ral simian leukemia viral oncogene homolog B [KO:K07835]
            5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            55770  EXOC2; exocyst complex component 2 [KO:K17637]
            29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]
            5966  REL; v-rel avian reticuloendotheliosis viral oncogene homolog [KO:K09254]
            5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]
            5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]
            10928  RALBP1; ralA binding protein 1 [KO:K08773]
            998  CDC42; cell division cycle 42 [KO:K04393]
            51196  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]
            5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
            5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
            5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
            9610  RIN1; Ras and Rab interactor 1 [KO:K17638]
            25  ABL1; ABL proto-oncogene 1, non-receptor tyrosine kinase [KO:K06619] [EC:2.7.10.2]
            27  ABL2; ABL proto-oncogene 2, non-receptor tyrosine kinase [KO:K08887] [EC:2.7.10.2]
            5868  RAB5A; RAB5A, member RAS oncogene family [KO:K07887]
            5869  RAB5B; RAB5B, member RAS oncogene family [KO:K07888]
            5878  RAB5C; RAB5C, member RAS oncogene family [KO:K07889]
            382  ARF6; ADP ribosylation factor 6 [KO:K07941]
COMPOUND    C00035  GDP
            C00044  GTP
            C00076  Calcium cation
            C00165  Diacylglycerol
            C00575  3',5'-Cyclic AMP
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:18568040
  AUTHORS   Karnoub AE, Weinberg RA
  TITLE     Ras oncogenes: split personalities.
  JOURNAL   Nat Rev Mol Cell Biol 9:517-31 (2008)
REFERENCE   PMID:12778136
  AUTHORS   Malumbres M, Barbacid M
  TITLE     RAS oncogenes: the first 30 years.
  JOURNAL   Nat Rev Cancer 3:459-65 (2003)
REFERENCE   PMID:21686117
  AUTHORS   Cox AD, Der CJ
  TITLE     Ras history: The saga continues.
  JOURNAL   Small GTPases 1:2-27 (2010)
REFERENCE   PMID:12642680
  AUTHORS   Cox AD, Der CJ
  TITLE     Ras family signaling: therapeutic targeting.
  JOURNAL   Cancer Biol Ther 1:599-606 (2002)
REFERENCE   PMID:17428555
  AUTHORS   Rajalingam K, Schreck R, Rapp UR, Albert S
  TITLE     Ras oncogenes and their downstream targets.
  JOURNAL   Biochim Biophys Acta 1773:1177-95 (2007)
REFERENCE   PMID:17384584
  AUTHORS   Schubbert S, Shannon K, Bollag G
  TITLE     Hyperactive Ras in developmental disorders and cancer.
  JOURNAL   Nat Rev Cancer 7:295-308 (2007)
REFERENCE   PMID:22233291
  AUTHORS   Poulogiannis G, Luo F, Arends MJ
  TITLE     RAS signalling in the colorectum in health and disease.
  JOURNAL   Cell Commun Adhes 19:1-9 (2012)
REFERENCE   PMID:22020205
  AUTHORS   Berndt N, Hamilton AD, Sebti SM
  TITLE     Targeting protein prenylation for cancer therapy.
  JOURNAL   Nat Rev Cancer 11:775-91 (2011)
REFERENCE   PMID:21196257
  AUTHORS   Overmeyer JH, Maltese WA
  TITLE     Death pathways triggered by activated Ras in cancer cells.
  JOURNAL   Front Biosci (Landmark Ed) 16:1693-713 (2011)
REFERENCE   PMID:16869784
  AUTHORS   Rodriguez-Viciana P, Tetsu O, Oda K, Okada J, Rauen K, McCormick F
  TITLE     Cancer targets in the Ras pathway.
  JOURNAL   Cold Spring Harb Symp Quant Biol 70:461-7 (2005)
REFERENCE   PMID:14663478
  AUTHORS   Cox AD, Der CJ
  TITLE     The dark side of Ras: regulation of apoptosis.
  JOURNAL   Oncogene 22:8999-9006 (2003)
REFERENCE   PMID:18413813
  AUTHORS   Braun BS, Shannon K
  TITLE     Targeting Ras in myeloid leukemias.
  JOURNAL   Clin Cancer Res 14:2249-52 (2008)
REFERENCE   PMID:20420946
  AUTHORS   Pino MS, Chung DC
  TITLE     The chromosomal instability pathway in colon cancer.
  JOURNAL   Gastroenterology 138:2059-72 (2010)
REFERENCE   PMID:12217381
  AUTHORS   Schrader JW, Schallhorn A, Grill B, Guo X
  TITLE     Activation of small GTPases of the Ras and Rho family by growth factors active on mast cells.
  JOURNAL   Mol Immunol 38:1181-6 (2002)
REFERENCE   PMID:22189424
  AUTHORS   Ahearn IM, Haigis K, Bar-Sagi D, Philips MR
  TITLE     Regulating the regulator: post-translational modification of RAS.
  JOURNAL   Nat Rev Mol Cell Biol 13:39-51 (2012)
REFERENCE   PMID:11313946
  AUTHORS   Ehrhardt GR, Korherr C, Wieler JS, Knaus M, Schrader JW
  TITLE     A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth.
  JOURNAL   Oncogene 20:188-97 (2001)
REFERENCE   PMID:16966426
  AUTHORS   Goldfinger LE, Ptak C, Jeffery ED, Shabanowitz J, Hunt DF, Ginsberg MH
  TITLE     RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration.
  JOURNAL   J Cell Biol 174:877-88 (2006)
REFERENCE   PMID:23506953
  AUTHORS   Kortum RL, Rouquette-Jazdanian AK, Samelson LE
  TITLE     Ras and extracellular signal-regulated kinase signaling in thymocytes and T cells.
  JOURNAL   Trends Immunol 34:259-68 (2013)
REFERENCE   PMID:15572660
  AUTHORS   Roberts DM, Anderson AL, Hidaka M, Swetenburg RL, Patterson C, Stanford WL, Bautch VL
  TITLE     A vascular gene trap screen defines RasGRP3 as an angiogenesis-regulated gene required for the endothelial response to phorbol esters.
  JOURNAL   Mol Cell Biol 24:10515-28 (2004)
REFERENCE   PMID:10712923
  AUTHORS   Reuther GW, Der CJ
  TITLE     The Ras branch of small GTPases: Ras family members don't fall far from the tree.
  JOURNAL   Curr Opin Cell Biol 12:157-65 (2000)
REFERENCE   PMID:21111786
  AUTHORS   Fernandez-Medarde A, Santos E
  TITLE     The RasGrf family of mammalian guanine nucleotide exchange factors.
  JOURNAL   Biochim Biophys Acta 1815:170-88 (2011)
REFERENCE   PMID:18437264
  AUTHORS   Iwashita S, Song SY
  TITLE     RasGAPs: a crucial regulator of extracellular stimuli for homeostasis of cellular functions.
  JOURNAL   Mol Biosyst 4:213-22 (2008)
REFERENCE   PMID:15062121
  AUTHORS   Ory S, Morrison DK
  TITLE     Signal transduction: implications for Ras-dependent ERK signaling.
  JOURNAL   Curr Biol 14:R277-8 (2004)
REFERENCE   PMID:19091743
  AUTHORS   Matheny SA, White MA
  TITLE     Signaling threshold regulation by the Ras effector IMP.
  JOURNAL   J Biol Chem 284:11007-11 (2009)
KO_PATHWAY  ko04014
///
ENTRY       hsa04020                    Pathway
NAME        Calcium signaling pathway - Homo sapiens (human)
DESCRIPTION Ca2+ that enters the cell from the outside is a principal source of signal Ca2+. Entry of Ca2+ is driven by the presence of a large electrochemical gradient across the plasma membrane. Cells use this external source of signal Ca2+ by activating various entry channels with widely different properties. The voltage-operated channels (VOCs) are found in excitable cells and generate the rapid Ca2+ fluxes that control fast cellular processes. There are many other Ca2+-entry channels, such as the receptor-operated channels (ROCs), for example the NMDA (N-methyl-D-aspartate) receptors (NMDARs) that respond to glutamate. There also are second-messenger-operated channels (SMOCs) and store-operated channels (SOCs).
            The other principal source of Ca2+ for signalling is the internal stores that are located primarily in the endoplasmic/sarcoplasmic reticulum (ER/SR), in which inositol-1,4,5-trisphosphate receptors (IP3Rs) or ryanodine receptors (RYRs) regulate the release of Ca2+. The principal activator of these channels is Ca2+ itself and this process of Ca2+-induced Ca2+ release is central to the mechanism of Ca2+ signalling. Various second messengers or modulators also control the release of Ca2+. IP3, which is generated by pathways using different isoforms of phospholipase C (PLCbeta, delta, epsilon, gamma and zeta), regulates the IP3Rs. Cyclic ADP-ribose (cADPR) releases Ca2+ via RYRs. Nicotinic acid adenine dinucleotide phosphate (NAADP) may activate a distinct Ca2+ release mechanism on separate acidic Ca2+ stores. Ca2+ release via the NAADP-sensitive mechanism may also feedback onto either RYRs or IP3Rs. cADPR and NAADP are generated by CD38. This enzyme might be sensitive to the cellular metabolism, as ATP and NADH inhibit it.
            The influx of Ca2+ from the environment or release from internal stores causes a very rapid and dramatic increase in cytoplasmic calcium concentration, which has been widely exploited for signal transduction. Some proteins, such as troponin C (TnC) involved in muscle contraction, directly bind to and sense Ca2+. However, in other cases Ca2+ is sensed through intermediate calcium sensors such as calmodulin (CALM).
CLASS       Environmental Information Processing; Signal transduction
PATHWAY_MAP hsa04020  Calcium signaling pathway
DISEASE     H00441  Progressive osseous heteroplasia (POH)
            H00608  46,XY disorders of sex development (Disorders in androgen synthesis or action)
            H00627  Premature ovarian failure
            H00699  Central core disease
            H00715  Darier disease
            H00728  Brugada syndrome (BRS)
            H00746  Hypokalemic periodic paralysis (HypoPP)
            H00749  Episodic ataxias
            H00755  Acrokeratosis verruciformis
            H00759  Waardenburg syndrome (WS)
            H00775  Familial or sporadic hemiplegic migraine
            H00787  Congenital stationary night blindness (CSNB)
            H00801  Familial thoracic aortic aneurysm and dissection (TAAD)
            H00823  ABCD syndrome
            H00865  Lethal congenital contractural syndrome (LCCS)
            H00910  Hirschsprung disease (HD)
            H00937  Precocious puberty
            H01019  Catecholaminergic polymorphic ventricular tachycardia
            H01118  Progressive external ophthalmoplegia (PEO)
            H01129  Brody myopathy
            H01307  Nonsyndromic congenital nail disorder (NDNC)
            H01310  Multi-minicore disease (MmD)
DRUG        D00045  Adenosine (JAN/USP)
            D00059  Levodopa (JP17/USP/INN)
            D00076  Noradrenaline (JP17)
            D00081  Dinoprost (JP17/USAN/INN)
            D00089  Oxytocin (JP17/USP/INN)
            D00095  Adrenaline (JP17)
            D00101  Vasopressin (JP17/USP)
            D00113  Atropine (USP)
            D00124  Ephedrine (USP)
            D00138  Scopolamine (INN)
            D00147  Hyoscyamine (USP)
            D00150  Angiotensin II (INN)
            D00176  Protirelin (JP17/USAN/INN)
            D00180  Alprostadil (JP17/USP/INN)
            D00227  Aminophylline (USP/INN)
            D00232  Methyloctatropine bromide (JAN)
            D00234  Astemizole (JAN/USP/INN)
            D00235  Atenolol (JP17/USP/INN)
            D00255  Carvedilol (JAN/USAN/INN)
            D00270  Chlorpromazine (USP/INN)
            D00274  Cisapride (USAN/INN)
            D00283  Clozapine (JAN/USP/INN)
            D00291  Desmopressin (INN)
            D00295  Cimetidine (JP17/USP/INN)
            D00300  Diphenhydramine (JP17/INN)
            D00304  Divalproex sodium (USP)
            D00318  Famotidine (JP17/USP/INN)
            D00319  Felodipine (JAN/USP/INN)
            D00349  Isradipine (USP/INN)
            D00356  Latanoprost (JAN/USAN/INN)
            D00357  Losartan potassium (JP17/USAN)
            D00364  Loratadine (JAN/USAN/INN)
            D00366  Lypressin (USP/INN)
            D00371  Theophylline (JP17)
            D00374  Tiotixene (JAN)
            D00378  Timolol (USAN)
            D00397  Tropicamide (JP17/USP/INN)
            D00399  Valproic acid (USP)
            D00400  Valsartan (JP17/USAN/INN)
            D00403  Levomepromazine (USAN/INN)
            D00411  Zafirlukast (JAN/USAN/INN)
            D00422  Ranitidine (USAN/INN)
            D00426  Risperidone (JP17/USAN/INN)
            D00432  Nadolol (JP17/USP/INN)
            D00437  Nifedipine (JP17/USP/INN)
            D00438  Nimodipine (USAN/INN)
            D00440  Nizatidine (JP17/USP/INN)
            D00454  Olanzapine (JAN/USAN/INN)
            D00458  Quetiapine fumarate (JP17/USAN)
            D00465  Oxybutynin (USAN/INN)
            D00480  Promethazine hydrochloride (JP17/USP)
            D00481  Propantheline bromide (JP17/USP/INN)
            D00483  Propranolol hydrochloride (JP17/USP)
            D00485  Pseudoephedrine hydrochloride (USP)
            D00494  Promethazine (JAN/INN)
            D00502  Pergolide mesilate (JAN)
            D00507  Phenoxybenzamine hydrochloride (USP)
            D00509  Phentolamine mesilate (JAN/INN)
            D00511  Phenylephrine hydrochloride (JP17/USP)
            D00513  Pindolol (JP17/USP/INN)
            D00520  Dimenhydrinate (JP17/USP/INN)
            D00521  Terfenadine (JAN/USAN/INN)
            D00522  Candesartan (USAN/INN)
            D00523  Irbesartan (JP17/USAN/INN)
            D00524  Carbachol (JAN/USP/INN)
            D00525  Pilocarpine (JAN/USP)
            D00528  Anhydrous caffeine (JP17)
            D00529  Montelukast sodium (JP17/USAN)
            D00537  Topiramate (JAN/USAN/INN)
            D00538  Zonisamide (JAN/USAN/INN)
            D00539  Ethosuximide (JP17/USP/INN)
            D00540  Glycopyrronium bromide (JAN/INN)
            D00560  Pimozide (JP17/USP/INN)
            D00561  Sertindole (USAN/INN)
            D00563  Mirtazapine (JAN/USAN/INN)
            D00597  Acebutolol hydrochloride (JP17/USP)
            D00598  Betaxolol hydrochloride (JP17/USP)
            D00599  Carteolol hydrochloride (JP17/USP)
            D00600  Labetalol hydrochloride (JP17/USP)
            D00601  Metoprolol tartrate (JP17/USP)
            D00602  Penbutolol sulfate (JP17/USP)
            D00603  Timolol maleate (JP17/USP)
            D00607  Guanadrel sulfate (USP)
            D00608  Doxazosin mesilate (JP17)
            D00609  Prazosin hydrochloride (JP17/USP)
            D00610  Terazosin hydrochloride hydrate (JAN)
            D00611  Mecamylamine hydrochloride (USP)
            D00613  Fenoldopam mesylate (USP)
            D00615  Amlodipine besilate (JP17)
            D00616  Diltiazem hydrochloride (JP17/USP)
            D00617  Nicardipine hydrochloride (JP17/USAN)
            D00618  Nisoldipine (JAN/USAN/INN)
            D00619  Verapamil hydrochloride (JP17/USP)
            D00626  Candesartan cilexetil (JP17/USAN)
            D00627  Telmisartan (JP17/USAN/INN)
            D00629  Nitrendipine (JP17/USAN/INN)
            D00631  Bepridil hydrochloride hydrate (JAN)
            D00632  Dobutamine hydrochloride (JP17/USP)
            D00633  Dopamine hydrochloride (JP17/USP)
            D00634  Bisoprolol fumarate (JP17/USP)
            D00635  Metoprolol succinate (USP)
            D00636  Amiodarone hydrochloride (JP17/USAN)
            D00644  Esmolol hydrochloride (JAN/USAN)
            D00646  Tolterodine (USAN/INN)
            D00659  Azelastine hydrochloride (JP17/USAN)
            D00661  Cevimeline hydrochloride hydrate (JAN)
            D00662  Azatadine maleate (USP)
            D00663  Brompheniramine maleate (USAN)
            D00664  Cetirizine hydrochloride (JP17/USAN)
            D00665  Chlorpheniramine maleate (JP17/USP)
            D00666  Clemastine fumarate (JP17/USP)
            D00668  d-Chlorpheniramine maleate (JP17)
            D00669  Diphenhydramine hydrochloride (JP17/USP)
            D00671  Fexofenadine hydrochloride (JP17/USAN)
            D00672  Hydroxyzine hydrochloride (JP17/USP)
            D00673  Ranitidine hydrochloride (JP17/USP)
            D00679  Ergotamine tartrate (JP17/USP)
            D00680  Methylergometrine maleate (JP17)
            D00682  Carboprost tromethamine (USP)
            D00683  Salbutamol sulfate (JP17)
            D00684  Bitolterol mesilate (JAN)
            D00685  Orciprenaline sulfate (JP17)
            D00686  Pirbuterol acetate (USAN)
            D00687  Salmeterol xinafoate (JAN/USAN)
            D00688  Terbutaline sulfate (JP17/USP)
            D00710  Sodium valproate (JP17)
            D00711  Ketamine hydrochloride (JP17/USP)
            D00715  Hyoscine methobromide (INN)
            D00717  Dicyclomine hydrochloride (JAN/USP)
            D00719  Hyoscyamine sulfate (USP)
            D00720  Mepenzolate bromide (JP17/INN)
            D00721  Methanthelinium bromide (INN)
            D00722  Oxybutynin hydrochloride (JAN)
            D00723  Tridihexethyl chloride (BAN)
            D00726  Metoclopramide (JP17/INN)
            D00740  Procaine hydrochloride (JP17/USP)
            D00743  Naphazoline hydrochloride (JP17/USP)
            D00756  Tetrahydrozoline nitrate (JAN)
            D00757  Xylometazoline hydrochloride (USP)
            D00774  Orphenadrine citrate (USP)
            D00777  Amantadine hydrochloride (JP17/USP)
            D00778  Benztropine mesilate (JAN)
            D00779  Biperiden (JAN/USP/INN)
            D00782  Procyclidine hydrochloride (USP)
            D00787  Trihexyphenidyl hydrochloride (JP17/USP)
            D00789  Chlorpromazine hydrochloride (JP17/USP)
            D00819  Nefazodone hydrochloride (USAN)
            D00820  Trazodone hydrochloride (JAN/USP)
            D00848  Dextromethorphan hydrobromide hydrate (JP17)
            D00996  Epinephrine hydrochloride (JAN)
            D00997  Tolazoline hydrochloride (JAN/USP)
            D00999  Acetylcholine chloride (JP17/USP/INN)
            D01000  Bethanechol chloride (JP17/USP)
            D01002  Cyclopentolate hydrochloride (JP17/USP)
            D01003  Hexocyclium metilsulfate (INN)
            D01004  Homatropine hydrobromide (JP17/USP)
            D01005  Isopropamide iodide (JAN/USP/INN)
            D01006  Oxyphencyclimine hydrochloride (JAN)
            D01007  Propiverine hydrochloride (JP17)
            D01017  Dipivefrin hydrochloride (JAN/USP)
            D01019  Metaraminol bitartrate (JAN/USP)
            D01020  Methoxamine hydrochloride (JAN)
            D01021  Naphazoline nitrate (JP17)
            D01022  Oxymetazoline hydrochloride (JAN/USP)
            D01023  Tetrahydrozoline hydrochloride (JAN/USP)
            D01024  Tamsulosin hydrochloride (JP17/USAN)
            D01025  Levobunolol hydrochloride (JAN/USP)
            D01026  Sotalol hydrochloride (JAN/USP)
            D01044  Flupentixol (INN)
            D01051  Spiperone (JAN/USAN)
            D01077  Atropine methonitrate (JAN/INN)
            D01096  Hydroxyzine pamoate (JP17/USP)
            D01103  Trospium chloride (JAN/USAN/INN)
            D01104  Barnidipine hydrochloride (JAN)
            D01117  Mizolastine (JAN/INN)
            D01118  Profenamine hydrochloride (JAN)
            D01123  Seratrodast (JAN/USAN/INN)
            D01128  Ramatroban (JAN/INN)
            D01131  Lafutidine (JP17/INN)
            D01143  Isothipendyl hydrochloride (JAN)
            D01145  Azelnidipine (JP17/INN)
            D01148  Tolterodine tartrate (JAN/USAN)
            D01163  Ergometrine maleate (JP17)
            D01164  Aripiprazole (JAN/USAN/INN)
            D01165  Piperidolate hydrochloride (JAN)
            D01172  Diphenylpyraline hydrochloride (JAN)
            D01173  Cilnidipine (JP17/INN)
            D01174  Pheniramine maleate (JAN/USP)
            D01175  Carpronium chloride (JAN/INN)
            D01176  Blonanserin (JAN/INN)
            D01182  Alprenolol hydrochloride (JP17/USAN)
            D01192  Olopatadine hydrochloride (JP17/USAN)
            D01193  Osutidine (JAN/INN)
            D01201  Tiemonium iodide (JAN/INN)
            D01204  Olmesartan medoxomil (JP17/USAN)
            D01227  Bosentan hydrate (JAN)
            D01231  Piroheptine hydrochloride (JAN)
            D01236  Conivaptan hydrochloride (JAN/USAN)
            D01242  Promethazine teoclate (JAN/INN)
            D01263  Ritodrine hydrochloride (JP17/USP)
            D01269  Solifenacin succinate (JAN/USAN/INN)
            D01290  Nicergoline (JP17/USAN/INN)
            D01295  Cinnarizine (JAN/USAN/INN)
            D01297  Pirenzepine hydrochloride (USAN)
            D01303  Flunarizine hydrochloride (JAN/USAN)
            D01307  Midodrine hydrochloride (JAN/USAN)
            D01315  Methylbenactyzium bromide (JP17/INN)
            D01317  Meclizine hydrochloride (JAN/USP)
            D01321  Zotepine (JAN/INN)
            D01324  Mequitazine (JP17/INN)
            D01332  Ketotifen fumarate (JP17/USAN)
            D01333  Urapidil (JP17/INN)
            D01336  Carbinoxamine maleate (JAN/USP)
            D01343  Dimetindene maleate (JAN)
            D01347  Tramazoline hydrochloride (JAN/USAN)
            D01349  Pirbuterol hydrochloride (JAN/USAN)
            D01352  Dinoprost tromethamine (JAN/USP)
            D01358  Mianserin hydrochloride (JAN/USAN)
            D01359  Etomidoline (JAN/INN)
            D01360  Clenbuterol hydrochloride (JAN/USP)
            D01362  Tulobuterol hydrochloride (JP17)
            D01369  Bevantolol hydrochloride (JAN/USAN)
            D01373  Formoterol fumarate (USAN)
            D01377  Prifinium bromide (JAN/INN)
            D01386  Ephedrine hydrochloride (JP17/USP)
            D01390  dl-Isoprenaline hydrochloride (JAN)
            D01405  Norfenefrine hydrochloride (JAN)
            D01428  Fenoterol hydrobromide (JAN)
            D01441  Imatinib mesylate (USAN)
            D01444  Bunitrolol hydrochloride (JAN)
            D01445  Ifenprodil tartrate (JP17)
            D01451  Scopolamine butylbromide (JP17)
            D01452  Isopropyl unoprostone (JAN)
            D01453  Caffeine hydrate (JP17)
            D01454  Bupranolol hydrochloride (JP17)
            D01460  Homochlorcyclizine hydrochloride (JP17)
            D01463  Diponium bromide (JAN/INN)
            D01467  Roxatidine acetate hydrochloride (JP17/USAN)
            D01469  Amosulalol hydrochloride (JP17)
            D01471  Esatenolol (JAN/INN)
            D01477  Opipramol hydrochloride (JAN/USAN)
            D01478  Ebastine (JP17/USAN/INN)
            D01482  Pipamperone hydrochloride (JAN)
            D01491  Butropium bromide (JP17/INN)
            D01500  Trimebutine maleate (JP17)
            D01504  Bufetolol hydrochloride (JP17)
            D01512  Befunolol hydrochloride (JAN)
            D01520  Levomepromazine hydrochloride (JAN/USAN)
            D01521  Pipethanate hydrochloride (JAN)
            D01538  Valethamate bromide (JAN)
            D01543  Nylidrin hydrochloride (JAN)
            D01548  Mosapramine hydrochloride (JAN)
            D01553  Manidipine hydrochloride (JP17)
            D01562  Aranidipine (JAN/INN)
            D01571  Moxisylyte hydrochloride (JAN)
            D01573  Etilefrine hydrochloride (JP17)
            D01589  Mabuterol hydrochloride (JAN)
            D01592  Betahistine mesilate (JP17)
            D01600  Diphenylpiperidinomethyldioxolan iodide (JAN)
            D01604  Efonidipine hydrochloride ethanolate (JAN)
            D01624  Sarpogrelate hydrochloride (JP17)
            D01627  Diphenylpyraline teoclate (JAN)
            D01635  Methoxyphenamine hydrochloride (JAN)
            D01648  Hyoscyamine methylbromide (JAN)
            D01652  Apafant (JAN/USAN/INN)
            D01654  Bepotastine besilate (JP17)
            D01674  Naftopidil (JP17/INN)
            D01691  Nipradilol (JAN/INN)
            D01692  Alfuzosin hydrochloride (JAN/USAN)
            D01697  Colforsin daropate hydrochloride (JAN)
            D01698  Dalcotidine (JAN/INN)
            D01699  Darifenacin hydrobromide (JAN/USAN)
            D01712  Theophylline sodium acetate (JAN)
            D01713  Epinastine hydrochloride (JAN)
            D01717  Levocabastine hydrochloride (JAN/USAN)
            D01741  Celiprolol hydrochloride (JAN/USAN)
            D01742  Clebopride malate (JP17)
            D01748  Isoxsuprine hydrochloride (JP17/USP)
            D01771  Proxyphylline (JAN/INN)
            D01773  Oxatomide (JAN/USAN/INN)
            D01782  Triprolidine hydrochloride hydrate (JAN)
            D01794  Bopindolol malonate (JAN)
            D01795  Tilisolol hydrochloride (JAN)
            D01801  Thonzylamine hydrochloride (JAN/USAN)
            D01806  Oxprenolol hydrochloride (JP17/USP)
            D01815  Oxapium iodide (JP17/INN)
            D01818  Proglumide (JP17/USAN/INN)
            D01830  Arotinolol hydrochloride (JP17)
            D01835  Clorprenaline hydrochloride (JAN/USAN)
            D01847  Landiolol hydrochloride (JAN)
            D01849  Lercanidipine hydrochloride (JAN/USAN)
            D01858  Panazepide (JAN)
            D01861  Pibutidine hydrochloride (JAN)
            D01869  Ornoprostil (JAN/INN)
            D01871  Metixene hydrochloride (JAN)
            D01875  Tiquizium bromide (JAN/INN)
            D01887  Bunazosin hydrochloride (JP17)
            D01902  Dimetotiazine mesilate (JAN)
            D01908  Nilvadipine (JP17/USAN/INN)
            D01922  Pratosartan (JAN/INN)
            D01925  Taltirelin hydrate (JP17)
            D01929  Tiotropium bromide hydrate (JAN)
            D01939  Ziprasidone hydrochloride hydrate (JAN)
            D01946  Oxitropium bromide (JAN/INN)
            D01952  L-Methylephedrine hydrochloride (JAN)
            D01955  Aclatonium napadisilate (JAN)
            D01958  Indenolol hydrochloride (JP17)
            D01964  Travoprost (JAN/USAN/INN)
            D01965  Silodosin (JP17/INN)
            D01969  Gallopamil hydrochloride (JAN)
            D01976  N-Methylscopolamine methylsulfate (JAN)
            D01977  Gefitinib (JAN/USAN/INN)
            D01978  Trimetoquinol hydrochloride
            D01987  Pipethanate ethobromide (JAN)
            D01994  Mosapride citrate hydrate (JP17)
            D02004  Apomorphine hydrochloride hydrate (JAN)
            D02007  Protirelin tartrate hydrate (JP17)
            D02014  Angiotensin II (human type) (JAN)
            D02017  Choline theophylline (JAN)
            D02034  Setiptiline maleate (JAN)
            D02045  Benidipine hydrochloride (JP17)
            D02066  Isoprenaline sulfate (JAN)
            D02069  Atropine sulfate (JP17/USP)
            D02070  Homatropine methylbromide (USP)
            D02071  Scopolamine hydrobromide hydrate (JP17)
            D02073  Gemeprost (JAN/USAN/INN)
            D02081  Metipranolol hydrochloride
            D02082  Eprosartan mesylate (USAN)
            D02090  Cyclizine lactate (BAN)
            D02091  Tripelennamine hydrochloride (USP)
            D02092  Cisapride (JAN)
            D02093  Isoetharine hydrochloride (USP)
            D02100  Ziprasidone mesylate (USAN)
            D02102  Methadone hydrochloride (JAN/USP)
            D02109  dl-Methylephedrine hydrochloride (JP17)
            D02147  Albuterol (USP)
            D02148  Phenindamine tartrate (USAN)
            D02149  Epinephrine bitartrate (JAN/USP)
            D02150  l-Isoprenaline hydrochloride (JP17)
            D02151  Tulobuterol (JP17/INN)
            D02200  Pilocarpine hydrochloride (JP17/USP)
            D02202  Lobeline hydrochloride (JAN)
            D02204  Hexamethonium bromide (JAN/INN)
            D02211  Dihydroergotamine mesilate (JP17)
            D02212  Ipratropium bromide hydrate (JP17)
            D02213  Metoclopramide hydrochloride (JAN)
            D02234  Cyproheptadine hydrochloride (JP17/USP)
            D02235  Desmopressin acetate hydrate (JAN)
            D02236  Flupentixol dihydrochloride (JAN)
            D02245  Alimemazine tartrate (JP17)
            D02246  Biperiden hydrochloride (JP17/USP)
            D02247  Biperiden lactate (JAN/USP)
            D02248  Levomepromazine maleate (JP17/USAN)
            D02249  Emedastine difumarate (JP17/USP)
            D02274  Dantrolene sodium hydrate (JP17)
            D02281  Levalbuterol hydrochloride (USAN)
            D02327  Doxylamine succinate (USP)
            D02338  Acebutolol (USAN/INN)
            D02342  Bisoprolol (JAN/USAN/INN)
            D02343  Carboprost (USAN/INN)
            D02347  Dantrolene (USAN/INN)
            D02349  Dipivefrin (USAN)
            D02356  Verapamil (USAN/INN)
            D02358  Metoprolol (USAN/INN)
            D02359  Ritodrine (USAN/INN)
            D02363  Ketanserin (USAN/INN)
            D02364  Lobeline (INN)
            D02372  Perospirone hydrochloride hydrate (JAN)
            D02374  Metipranolol (USAN/INN)
            D02384  Verlukast (USAN/INN)
            D02389  Primidolol (USAN/INN)
            D02396  Hexoprenaline sulfate (USAN)
            D02404  Procaterol hydrochloride (USAN)
            D02410  Selfotel (USAN/INN)
            D02417  Flutropium bromide (JAN)
            D02419  Diphenhydramine salicylate (JAN)
            D02535  Timepidium bromide hydrate (JP17)
            D02537  Dronedarone (INN)
            D02577  Flibanserin (USAN/INN)
            D02578  Agomelatine (INN)
            D02588  Montirelin (INN)
            D02590  Israpafant (JAN/INN)
            D02599  Orphenadrine hydrochloride
            D02612  Thiothixene hydrochloride (USP)
            D02613  Clopenthixol (USAN)
            D02614  Denopamine (JAN/INN)
            D02622  Pipamperone (USAN/INN)
            D02630  Penfluridol (USAN/INN)
            D02641  Butaclamol hydrochloride (USAN)
            D02656  Fananserin (USAN/INN)
            D02666  Iloperidone (USAN/INN)
            D02676  Oxiperomide (USAN/INN)
            D02692  Human menopausal gonadotrophin (JP17)
            D02693  Devazepide (USAN/INN)
            D02702  Talibegron hydrochloride (USAN)
            D02705  Alprostadil alfadex (JP17)
            D02710  Tarazepide (INN)
            D02719  Rosaprostol (INN)
            D02722  Limaprost (INN)
            D02724  Bimatoprost (JAN/USAN/INN)
            D02730  Tegaserod maleate (USAN)
            D02732  Pranlukast hydrate (JP17)
            D02739  Ablukast (USAN/INN)
            D02741  Ablukast sodium (USAN)
            D02750  Aceclidine (USAN/INN)
            D02760  Acrivastine (USAN/INN)
            D02765  Adaprolol maleate (USAN)
            D02767  Adatanserin hydrochloride (USAN)
            D02775  Adrogolide hydrochloride (USAN)
            D02780  Acamprosate calcium (JAN/USAN)
            D02834  Alprenoxime hydrochloride (USAN)
            D02836  Altanserin tartrate (USAN)
            D02846  Cinalukast (USAN/INN)
            D02848  Pobilukast edamine (USAN)
            D02849  Ritolukast (USAN/INN)
            D02850  Sulukast (USAN/INN)
            D02851  Tomelukast (USAN/INN)
            D02860  Limaprost alfadex (JP17)
            D02876  Alvameline maleate (USAN)
            D02893  Amesergide (USAN/INN)
            D02901  Amidephrine mesylate (USAN)
            D02910  Amiodarone (USAN/INN)
            D02914  Amlodipine maleate (USAN)
            D02939  Angiotensin amide (USAN)
            D02950  Antazoline phosphate (USP)
            D02968  Aprepitant (JAN/USAN/INN)
            D02973  Aptiganel hydrochloride (USAN)
            D02976  Arbutamine hydrochloride (USAN)
            D02981  Arformoterol tartrate (USAN)
            D02983  Argipressin tannate (USAN)
            D02995  Asenapine maleate (JAN/USAN)
            D03008  Atosiban (USAN/INN)
            D03009  Atrasentan hydrochloride (USAN)
            D03011  Atropine oxide hydrochloride (USAN)
            D03065  Becaplermin (USAN/INN)
            D03087  Benzetimide hydrochloride (USAN)
            D03102  Betahistine hydrochloride (USP)
            D03120  Binodenoson (USAN/INN)
            D03166  Bromodiphenhydramine hydrochloride (USP)
            D03170  Bucindolol hydrochloride (USAN)
            D03177  Bunolol hydrochloride (USAN)
            D03195  Butopamine (USAN/INN)
            D03198  Butoxamine hydrochloride (USAN)
            D03212  Apadenoson (USAN)
            D03218  Axitinib (JAN/USAN)
            D03221  Befetupitant (USAN/INN)
            D03264  Mazaticol hydrochloride hydrate (JAN)
            D03274  Chlorpromazine hibenzate (JAN)
            D03276  Profenamine hibenzate (JAN)
            D03285  Diphenhydramine tannate (JP17)
            D03290  Promethazine methylenedisalicylate (JAN)
            D03350  Canertinib dihydrochloride (USAN)
            D03360  Diphenhydramine laurylsulfate (JAN)
            D03399  Carboprost methyl (USAN)
            D03402  Carbuterol hydrochloride (USAN)
            D03415  Carvedilol phosphate hydrate (JAN)
            D03449  Cetamolol hydrochloride (USAN)
            D03455  Cetuximab (genetical recombination) (JAN)
            D03475  Chlorpheniramine polistirex (USAN)
            D03478  Choriogonadotropin alfa (genetical recombination) (JAN)
            D03490  Cicloprolol hydrochloride (USAN)
            D03494  Ciladopa hydrochloride (USAN)
            D03502  Cimaterol (USAN/INN)
            D03503  Cimetidine hydrochloride (USP)
            D03506  Cinanserin hydrochloride (USAN)
            D03534  Clebopride (USAN)
            D03535  Clemastine (USAN)
            D03556  Zuclopenthixol (INN)
            D03587  Colterol mesylate (USAN)
            D03621  Cyclizine (INN)
            D03622  Cyclizine hydrochloride (USP)
            D03642  Daltroban (USAN/INN)
            D03648  Dapiprazole hydrochloride (USAN)
            D03654  Darifenacin (USAN/INN)
            D03655  Darodipine (USAN/INN)
            D03658  Dasatinib (INN)
            D03677  Deltibant (USAN/INN)
            D03679  Delucemine hydrochloride (USAN)
            D03693  Desloratadine (JAN/USAN/INN)
            D03704  Dexbrompheniramine maleate (USAN)
            D03711  Dexetimide (USAN/INN)
            D03729  Dexpropranolol hydrochloride (USAN)
            D03742  Dextromethorphan (USP)
            D03744  Dextromethorphan polistirex (USAN)
            D03746  Dextrorphan hydrochloride (USAN)
            D03759  Diacetolol hydrochloride (USAN)
            D03814  Atropine methylbromide (JAN)
            D03830  Diltiazem malate (USAN)
            D03854  Diphenhydramine citrate (USP)
            D03878  Dizocilpine maleate (USAN)
            D03879  Dobutamine (USP/INN)
            D03880  Dobutamine lactobionate (USAN)
            D03881  Dobutamine tartrate (USP)
            D03889  Donetidine (USAN)
            D03891  Dopexamine (USAN/INN)
            D03914  Dronedarone hydrochloride (USAN)
            D03937  Ecopipam hydrochloride (USAN)
            D03953  Edonentan (USAN)
            D04018  Ephedrine sulfate (USP)
            D04023  Erlotinib hydrochloride (JAN/USAN)
            D04024  Lapatinib tosilate hydrate (JAN)
            D04025  Mubritinib (USAN/INN)
            D04034  Chlorpromazine phenolphthalinate (JAN)
            D04040  Eprosartan (USAN/INN)
            D04057  Esoxybutynin chloride (USAN)
            D04074  Etalocib (USAN)
            D04087  Ethybenztropine (USAN)
            D04098  Etintidine hydrochloride (USAN)
            D04116  Eucatropine hydrochloride (USP XXXII)
            D04126  Saralasin acetate (USAN)
            D04137  Felypressin (USAN/INN)
            D04155  Fenobam (USAN)
            D04157  Fenoterol (USAN/INN)
            D04184  Fiduxosin hydrochloride (USAN)
            D04190  Flestolol sulfate (USAN)
            D04226  Flupirtine maleate (USAN)
            D04243  Forasartan (USAN/INN)
            D04308  Gavestinel (USAN/INN)
            D04320  Glemanserin (USAN/INN)
            D04479  Hyoscyamine hydrobromide (USP)
            D04488  Ibopamine (USAN/INN)
            D04492  Icatibant acetate (USAN)
            D04494  Icotidine (USAN)
            D04500  Ifetroban (USAN/INN)
            D04501  Ifetroban sodium (USAN)
            D04517  Impromidine hydrochloride (USAN)
            D04531  Indoramin (USAN/INN)
            D04532  Indoramin hydrochloride (USAN)
            D04625  Isoetharine (USP)
            D04626  Isoetharine mesylate (USP)
            D04641  Istradefylline (JAN/USAN/INN)
            D04657  Lacidipine (USAN/INN)
            D04680  Lavoltidine succinate (USAN)
            D04701  Levalbuterol sulfate (USAN)
            D04703  Levalbuterol tartrate (USAN)
            D04708  Levdobutamine lactobionate (USAN)
            D04710  Levobetaxolol hydrochloride (USAN)
            D04724  Lexipafant (USAN/INN)
            D04728  Licostinel (USAN/INN)
            D04788  Lubazodone hydrochloride (USAN)
            D04794  Lupitidine hydrochloride (USAN)
            D04820  Lurasidone hydrochloride (JAN/USAN)
            D04824  Lutropin alfa (USAN/INN)
            D04860  Maropitant citrate (USAN)
            D04888  Medroxalol (USAN/INN)
            D04889  Medroxalol hydrochloride (USAN)
            D04905  Memantine hydrochloride (JAN/USAN)
            D04954  Metaproterenol polistirex (USAN)
            D04970  Methacholine chloride (JAN/USAN/INN)
            D05004  Metiamide (USAN/INN)
            D05008  Metoclopramide hydrochloride (USAN)
            D05011  Metoprolol fumarate (USP)
            D05015  Metrenperone (USAN/INN)
            D05024  Mibefradil dihydrochloride (USAN)
            D05029  Midostaurin (USAN/INN)
            D05035  Milameline hydrochloride (USAN)
            D05037  Trimetoquinol hydrochloride hydrate (JP17)
            D05085  Moxilubant maleate (USAN)
            D05107  Nafronyl oxalate (USAN)
            D05127  Nebivolol (USAN/INN)
            D05145  Neramexane mesylate (USAN)
            D05196  Noberastine (USAN/INN)
            D05206  Norepinephrine bitartrate (USP)
            D05246  Olmesartan (USAN/INN)
            D05258  Serum gonadotrophin (JAN)
            D05276  Pirenzepine hydrochloride hydrate (JP17)
            D05277  Formoterol fumarate hydrate (JP17)
            D05306  Oxmetidine hydrochloride (USAN)
            D05307  Oxmetidine mesylate (USAN)
            D05339  Paliperidone (JAN/USAN/INN)
            D05340  Paliperidone palmitate (JAN/USAN)
            D05345  Pamatolol sulfate (USAN)
            D05350  Panitumumab (genetical recombination) (JAN)
            D05366  Procaterol hydrochloride hydrate (JP17)
            D05380  Pazopanib hydrochloride (JAN/USAN)
            D05395  Pelanserin hydrochloride (USAN)
            D05399  Pelitinib (USAN/INN)
            D05429  Aminophylline hydrate (JP17)
            D05442  Perhexiline maleate (USAN)
            D05446  Pertuzumab (genetical recombination) (JAN)
            D05447  Perzinfotel (USAN/INN)
            D05453  Phencyclidine hydrochloride (USAN)
            D05471  Piboserod hydrochloride (USAN)
            D05476  Picumeterol fumarate (USAN)
            D05478  Pilocarpine nitrate (USP)
            D05523  Pizotyline (USAN)
            D05587  Practolol (USAN)
            D05606  Prenalterol hydrochloride (USAN)
            D05648  Pseudoephedrine polistirex (USAN)
            D05649  Pseudoephedrine sulfate (USP)
            D05660  Pyrilamine maleate (USP)
            D05691  Ractopamine hydrochloride (USAN)
            D05699  Ranitidine bismuth citrate (USAN)
            D05711  Regadenoson (USAN/INN)
            D05714  Remacemide hydrochloride (USAN)
            D05718  Reproterol hydrochloride (USAN)
            D05727  Ridogrel (USAN/INN)
            D05730  Rimiterol hydrobromide (USAN)
            D05738  Ritanserin (USAN/INN)
            D05742  Rocastine hydrochloride (USAN)
            D05779  Sabcomeline hydrochloride (USAN)
            D05792  Salmeterol (USAN/INN)
            D05832  Sibenadet hydrochloride (USAN)
            D05879  Solabegron hydrochloride (USAN)
            D05902  Soterenol hydrochloride (USAN)
            D05939  Sufotidine (USAN/INN)
            D05941  Sulamserod hydrochloride (USAN)
            D05970  Sulotroban (USAN/INN)
            D05996  Talnetant hydrochloride (USAN)
            D06000  Talsaclidine fumarate (USAN)
            D06005  Tandutinib (USAN/INN)
            D06015  Tazomeline citrate (USAN)
            D06021  Tecastemizole (USAN/INN)
            D06056  Tegaserod (USAN/INN)
            D06063  Temelastine (USAN/INN)
            D06103  Theophylline (USP)
            D06104  Theophylline sodium glycinate (USP)
            D06120  Thyrotropin alfa (genetical recombination) (JAN)
            D06140  Ticolubant (USAN/INN)
            D06146  Tiletamine hydrochloride (USP)
            D06157  Tiotidine (USAN/INN)
            D06234  Trimazosin hydrochloride (USAN)
            D06246  Tripelennamine citrate
            D06253  Tropanserin hydrochloride (USAN)
            D06272  Sorafenib tosilate (JAN)
            D06273  Imidafenacin (JAN/INN)
            D06274  Tafluprost (JAN/USAN/INN)
            D06280  Vapiprost hydrochloride (JAN/USAN)
            D06285  Vatalanib (USAN/INN)
            D06293  Vestipitant mesylate (USAN)
            D06317  Vofopitant dihydrochloride (USAN)
            D06328  Xamoterol (USAN)
            D06329  Xamoterol fumarate (USAN)
            D06330  Xanomeline (USAN)
            D06331  Xanomeline tartrate (USAN)
            D06353  Zacopride hydrochloride (USAN)
            D06355  Zaltidine hydrochloride (USAN)
            D06374  Zinterol hydrochloride (USAN)
            D06394  Dabuzalgron hydrochloride (USAN)
            D06396  Renzapride (INN)
            D06402  Sunitinib malate (JAN/USAN)
            D06407  Vandetanib (JAN/USAN/INN)
            D06413  Nilotinib hydrochloride hydrate (JAN)
            D06414  Dasatinib hydrate (JAN)
            D06457  Chorionic gonadotrophin (JP17)
            D06459  Purified human menopausal gonadotrophin (JAN)
            D06552  Alcaftadine (JAN/USAN/INN)
            D06574  Casopitant mesylate (USAN)
            D06597  Fosaprepitant meglumine (JAN)
            D06613  Lorcaserin hydrochloride (USAN)
            D06622  Nebivolol hydrochloride (USAN)
            D06623  Olanzapine pamoate (USAN)
            D06632  Pruvanserin (USAN/INN)
            D06633  Pruvanserin hydrochloride (USAN)
            D06646  Epanolol (USAN/INN)
            D06659  Tipelukast (USAN)
            D06672  Terlipressin (USAN/INN)
            D06678  Motesanib
            D07058  Acamprosate (INN)
            D07072  Niperotidine (INN)
            D07076  Camylofin (INN)
            D07077  Ambrisentan (JAN/INN)
            D07099  Cimetropium bromide (INN)
            D07124  Alfuzosin (INN)
            D07125  Alimemazine (INN)
            D07140  Picotamide (BAN)
            D07148  Oxedrine (BAN)
            D07156  Alprenolol (INN)
            D07171  Sitaxentan (USAN/INN)
            D07181  Mepindolol (INN)
            D07182  Tertatolol (INN)
            D07183  Cloranolol (INN)
            D07184  Talinolol (INN)
            D07185  Fendiline (INN)
            D07197  Bamipine (INN)
            D07198  Chlorphenoxamine (INN)
            D07218  Metergoline (INN)
            D07226  Fesoterodine (INN)
            D07227  Ornipressin (INN)
            D07228  Demoxytocin (INN)
            D07229  Carbetocin (INN/BAN)
            D07283  Esketamine (INN)
            D07349  Choline alfoscerate (INN)
            D07377  Bambuterol (INN)
            D07398  Chlorphenamine (INN)
            D07402  Levocetirizine (USAN/INN)
            D07406  Pimethixene (INN)
            D07407  Rupatadine (INN)
            D07441  Amantadine (INN)
            D07450  Amlodipine (USAN/INN)
            D07451  Amosulalol (INN)
            D07458  Antazoline (INN)
            D07459  Antazoline hydrochloride
            D07460  Apomorphine (BAN)
            D07463  Arformoterol (INN)
            D07465  Arotinolol (INN)
            D07475  Atosiban acetate
            D07477  Atropine oxide (INN)
            D07482  Azatadine (INN)
            D07483  Azelastine (INN)
            D07489  Bambuterol hydrochloride
            D07492  Bamipine dihydrochloride
            D07493  Bamipine lactate
            D07494  Barnidipine (INN)
            D07509  Benidipine (INN)
            D07511  Benzatropine (INN)
            D07513  Benzetimide (INN)
            D07520  Bepridil (INN)
            D07522  Betahistine (INN)
            D07526  Betaxolol (INN)
            D07534  Bitolterol (INN)
            D07537  Bopindolol (INN)
            D07538  Bosentan (INN)
            D07543  Brompheniramine (INN)
            D07550  Bunazosin (INN)
            D07551  Buphenine (INN)
            D07590  Bupranolol (INN)
            D07603  Caffeine citrate (USP)
            D07608  Carazolol (INN)
            D07617  Carbinoxamine (INN)
            D07624  Carteolol (INN)
            D07660  Celiprolol (INN)
            D07662  Cetirizine (INN)
            D07667  Cevimeline (INN)
            D07682  Clazosentan sodium (JAN)
            D07684  Chlorphenoxamine hydrochloride
            D07713  Clenbuterol (INN)
            D07734  Cinnarizine dihydrochloride
            D07741  Zibotentan (JAN/USAN/INN)
            D07748  Conivaptan (INN)
            D07759  Cyclopentolate (INN)
            D07765  Cyproheptadine (INN)
            D07803  Dexchlorpheniramine (INN)
            D07804  Dexetimide hydrochloride
            D07820  Dicycloverine (INN)
            D07837  Dihydroergotamine (INN)
            D07838  Dihydroergotamine tartrate
            D07845  Diltiazem (INN)
            D07853  Dimetindene (INN)
            D07854  Dimetotiazine (INN)
            D07860  Dioxopromethazine hydrochloride
            D07862  Diphenylpyraline (INN)
            D07870  Dopamine (INN)
            D07874  Doxazosin (INN)
            D07878  Doxylamine (INN)
            D07886  Efonidipine (INN)
            D07890  Emedastine (INN)
            D07900  Epinastine (INN)
            D07905  Ergometrine (INN)
            D07906  Ergotamine (INN)
            D07907  Erlotinib (INN)
            D07916  Esmolol (INN)
            D07931  Etilefrine (INN)
            D07951  Fentonium bromide (INN)
            D07958  Fexofenadine (INN)
            D07971  Flunarizine (INN)
            D07976  Flupentixol decanoate
            D07978  Flupirtine (INN)
            D07979  Flupirtine D-gluconate
            D07990  Formoterol (INN)
            D08009  Gallopamil (INN)
            D08039  Hexoprenaline (INN)
            D08040  Histamine (DCF)
            D08041  Homochlorcyclizine (INN)
            D08054  Hydroxyzine (INN)
            D08057  Ibopamine hydrochloride
            D08064  Ifenprodil (INN)
            D08066  Imatinib (INN)
            D08067  Azilsartan medoxomil (USAN)
            D08074  Penbutolol (INN)
            D08078  Indenolol (INN)
            D08090  Isoprenaline (INN)
            D08091  Isothipendyl (INN)
            D08092  Isoxsuprine (INN)
            D08093  Isoxsuprine lactate
            D08098  Ketamine (INN)
            D08099  Ketanserin tartrate
            D08100  Ketobemidone (INN)
            D08101  Ketobemidone hydrochloride
            D08105  Ketotifen (INN)
            D08106  Labetalol (INN)
            D08108  Lapatinib (INN)
            D08111  Lercanidipine (INN)
            D08115  Levobunolol (INN)
            D08117  Levocabastine (INN)
            D08118  Levocetirizine hydrochloride (JAN/USAN)
            D08121  Levomethadone (INN)
            D08122  Levomethadone hydrochloride
            D08124  Levosalbutamol (INN)
            D08138  Lobeline sulfate
            D08146  Losartan (INN)
            D08155  Manidipine (INN)
            D08157  Mazaticol (INN)
            D08163  Meclozine (BAN)
            D08174  Memantine (INN)
            D08183  Mepyramine (INN)
            D08184  Mepyramine theophyllineacetate
            D08192  Metaraminol (INN)
            D08195  Methadone (BAN)
            D08201  Methoxamine (BAN)
            D08206  Methylephedrine (BAN)
            D08207  Methylergometrine (INN)
            D08209  Metixene (INN)
            D08212  Trimazosin (INN)
            D08216  Mianserin (INN)
            D08217  Mibefradil (INN)
            D08220  Midodrine (INN)
            D08229  Montelukast (INN)
            D08235  Mosapramine (INN)
            D08236  Mosapride (INN)
            D08239  Moxisylyte (INN)
            D08244  Naftidrofuryl (INN)
            D08253  Naphazoline (INN)
            D08257  Nefazodone (INN)
            D08270  Nicardipine (INN)
            D08271  Nicergoline tartrate
            D08284  Norepinephrine hydrochoride
            D08286  Norfenefrine (INN)
            D08293  Olopatadine (INN)
            D08297  Opipramol (INN)
            D08300  Orciprenaline (INN)
            D08305  Orphenadrine (INN)
            D08308  Oxedrine tartrate
            D08309  Oxedrine hydrochloride
            D08318  Oxprenolol (INN)
            D08322  Oxymetazoline (INN)
            D08325  Oxyphencyclimine (INN)
            D08339  Pergolide (INN)
            D08353  Phenindamine (INN)
            D08355  Pheniramine (INN)
            D08358  Phenoxybenzamine (INN)
            D08362  Phentolamine (INN)
            D08365  Phenylephrine (INN)
            D08366  Phenylephrine tartrate
            D08376  Pilocarpine borate
            D08382  Piperidolate (INN)
            D08384  Pipethanate (INN)
            D08387  Pirbuterol (INN)
            D08389  Pirenzepine (INN)
            D08395  Piroheptine (INN)
            D08397  Pizotifen malate
            D08408  Pranlukast (INN)
            D08411  Prazosin (INN)
            D08424  Procaterol (INN)
            D08425  Procyclidine (INN)
            D08426  Profenamine (INN)
            D08432  Promethazine maleate
            D08441  Propiverine (INN)
            D08443  Propranolol (INN)
            D08449  Pseudoephedrine (INN)
            D08456  Quetiapine (INN)
            D08474  Reproterol (INN)
            D08494  Roxatidine (INN)
            D08495  Roxatidine acetate (BAN)
            D08497  Rupatadine fumarate (JAN)
            D08503  Toceranib (USAN)
            D08508  Sarpogrelate (INN)
            D08511  Setiptiline (INN)
            D08517  Sitaxentan sodium (USAN)
            D08522  Solifenacin (INN)
            D08524  Sorafenib (USAN/INN)
            D08525  Sotalol (INN)
            D08544  Toceranib phosphate (USAN)
            D08552  Sunitinib (INN)
            D08560  Tamsulosin (INN)
            D08569  Terazosin (INN)
            D08570  Terbutaline (INN)
            D08571  Terlipressin acetate (JAN)
            D08572  Tertatolol hydrochloride
            D08578  Tetryzoline (INN)
            D08587  Thonzylamine (INN)
            D08591  Tiaprost (INN)
            D08595  Tiemonium methylsulfate
            D08596  Tiletamine (INN)
            D08598  Tilisolol (INN)
            D08600  Timolol (INN)
            D08614  Tolazoline (INN)
            D08624  Tramazoline (INN)
            D08626  Trazodone (INN)
            D08629  Tretoquinol (INN)
            D08638  Trihexyphenidyl (INN)
            D08639  Trimebutine (INN)
            D08645  Tripelennamine (INN)
            D08648  Triprolidine (INN)
            D08661  Unoprostone (INN)
            D08662  Urapidil hydrochloride
            D08667  Calcium valproate
            D08684  Xylometazoline (INN)
            D08687  Ziprasidone (INN)
            D08691  Zuclopenthixol acetate
            D08692  Zuclopenthixol decanoate
            D08693  Zuclopenthixol dihydrochloride
            D08768  Promethazine hibenzate
            D08837  Aclidinium bromide (JAN/USAN/INN)
            D08850  Amibegron (USAN/INN)
            D08851  Amibegron hydrochloride (USAN)
            D08864  Azilsartan (JAN/USAN/INN)
            D08865  Azilsartan kamedoxomil (USAN)
            D08892  Clevidipine (USAN/INN)
            D08923  Fesoterodine fumarate (JAN/USP)
            D08937  Labradimil (INN/USAN)
            D08945  Milveterol hydrochloride (USAN)
            D08947  Motesanib phosphate (JAN)
            D08950  Neratinib (INN/USAN)
            D08953  Nilotinib (USAN/INN)
            D08966  Phenylephrine bitartrate (USP)
            D08969  Pimavanserin tartrate (USAN)
            D08986  Retosiban (USAN)
            D08988  Rolapitant hydrochloride (USAN)
            D09003  Sonedenoson (USAN)
            D09205  Prucalopride (USAN/INN)
            D09318  Indacaterol (USAN/INN)
            D09319  Indacaterol maleate (JAN/USAN)
            D09344  Fasobegron (INN)
            D09378  Serlopitant (USAN)
            D09402  Darotropium bromide (USAN/INN)
            D09535  Mirabegron (USAN/JAN)
            D09570  Bilastine (JAN/INN)
            D09645  Nelotanserin (USAN/INN)
            D09650  Orvepitant (USAN/INN)
            D09651  Orvepitant maleate (USAN)
            D09689  Varlitinib (USAN/INN)
            D09690  Varlitinib tosylate (USAN)
            D09693  Velusetrag (USAN/INN)
            D09694  Velusetrag hydrochloride (USAN)
            D09696  Vilanterol (USAN)
            D09697  Vilanterol trifenatate (JAN/USAN)
            D09705  Bepotastine (USAN/INN)
            D09717  Preladenant (USAN/INN)
            D09724  Afatinib (USAN/INN)
            D09732  Ritobegron ethyl hydrochloride (JAN)
            D09733  Afatinib maleate (JAN)
            D09752  Carpronium chloride hydrate (JAN)
            D09765  Vorapaxar (USAN/INN)
            D09766  Vorapaxar sulfate (JAN/USAN)
            D09774  Imitrodast sodium (JAN)
            D09784  Garomefrine hydrochloride (JAN)
            D09789  Kirenidipine hydrochloride (JAN)
            D09794  Norepinephrine hydrochloride (JAN)
            D09797  Cargutocin (INN/JAN)
            D09808  Carbinoxamine diphenyldisulfonate (JAN)
            D09819  Chlorpromazine tannate (JAN)
            D09820  Vasopressin tannate (JAN)
            D09842  dl-Methylephedrine saccharinate (JAN)
            D09845  Montirelin hydrate (JAN)
            D09866  Atopaxar (USAN)
            D09867  Atopaxar hydrobromide (USAN)
            D09883  Dacomitinib (USAN/INN)
            D09919  Lenvatinib (USAN/INN)
            D09920  Lenvatinib mesilate (JAN)
            D09933  Naronapride (USAN/INN)
            D09934  Naronapride dihydrochloride (USAN)
            D09939  Olaratumab (USAN/INN)
            D09976  Temanogrel (USAN/INN)
            D09977  Temanogrel hydrochloride (USAN)
            D09980  Trastuzumab emtansine (genetical recombination) (JAN)
            D09991  Vipadenant (USAN/INN)
            D10006  Eplivanserin (USAN/INN)
            D10018  Necitumumab (USAN/INN)
            D10020  Olodaterol hydrochloride (JAN/USAN)
            D10031  Zalutumumab (USAN/INN)
            D10062  Cabozantinib (USAN)
            D10099  Cerlapirdine (USAN)
            D10100  Cerlapirdine hydrochloride (USAN)
            D10102  Crenolanib (USAN)
            D10103  Crenolanib besylate (USAN)
            D10117  Epelsiban (USAN)
            D10118  Epelsiban besylate (USAN)
            D10135  Macitentan (JAN/USAN)
            D10137  Regorafenib hydrate (JAN)
            D10138  Regorafenib (USAN/INN)
            D10145  Olodaterol (USAN/INN)
            D10152  Prucalopride succinate (USAN)
            D10174  Tozadenant (USAN)
            D10180  Umeclidinium (USAN)
            D10181  Umeclidinium bromide (JAN/USAN)
            D10184  Vortioxetine (USAN)
            D10185  Vortioxetine hydrobromide (JAN/USAN)
            D10219  Abediterol (USAN/INN)
            D10220  Abediterol napadisylate (USAN)
            D10364  Aripiprazole lauroxil (USAN)
            D10386  Cindunistat (USAN/INN)
            D10391  Telmapitant (USAN)
            D10419  Cindunistat hydrochloride maleate (USAN)
            D10514  Dacomitinib hydrate (JAN)
            D10516  Aripiprazole hydrate (JAN)
            D10742  Rolapitant (USAN/INN)
DBLINKS     GO: 0019722
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        6546  SLC8A1; solute carrier family 8 member A1 [KO:K05849]
            6543  SLC8A2; solute carrier family 8 member A2 [KO:K05849]
            6547  SLC8A3; solute carrier family 8 member A3 [KO:K05849]
            490  ATP2B1; ATPase plasma membrane Ca2+ transporting 1 [KO:K05850] [EC:3.6.3.8]
            492  ATP2B3; ATPase plasma membrane Ca2+ transporting 3 [KO:K05850] [EC:3.6.3.8]
            493  ATP2B4; ATPase plasma membrane Ca2+ transporting 4 [KO:K05850] [EC:3.6.3.8]
            491  ATP2B2; ATPase plasma membrane Ca2+ transporting 2 [KO:K05850] [EC:3.6.3.8]
            1128  CHRM1; cholinergic receptor muscarinic 1 [KO:K04129]
            1131  CHRM3; cholinergic receptor muscarinic 3 [KO:K04131]
            1133  CHRM5; cholinergic receptor muscarinic 5 [KO:K04133]
            135  ADORA2A; adenosine A2a receptor [KO:K04266]
            136  ADORA2B; adenosine A2b receptor [KO:K04267]
            153  ADRB1; adrenoceptor beta 1 [KO:K04141]
            154  ADRB2; adrenoceptor beta 2 [KO:K04142]
            155  ADRB3; adrenoceptor beta 3 [KO:K04143]
            1812  DRD1; dopamine receptor D1 [KO:K04144]
            1816  DRD5; dopamine receptor D5 [KO:K05840]
            3274  HRH2; histamine receptor H2 [KO:K04150]
            3360  HTR4; 5-hydroxytryptamine receptor 4 [KO:K04160]
            3361  HTR5A; 5-hydroxytryptamine receptor 5A [KO:K04161]
            3362  HTR6; 5-hydroxytryptamine receptor 6 [KO:K04162]
            3363  HTR7; 5-hydroxytryptamine receptor 7 [KO:K04163]
            2778  GNAS; GNAS complex locus [KO:K04632]
            2774  GNAL; G protein subunit alpha L [KO:K04633]
            107  ADCY1; adenylate cyclase 1 (brain) [KO:K08041] [EC:4.6.1.1]
            108  ADCY2; adenylate cyclase 2 (brain) [KO:K08042] [EC:4.6.1.1]
            109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]
            196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]
            113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]
            114  ADCY8; adenylate cyclase 8 (brain) [KO:K08048] [EC:4.6.1.1]
            115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]
            5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
            5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
            5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
            5350  PLN; phospholamban [KO:K05852]
            487  ATP2A1; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 [KO:K05853] [EC:3.6.3.8]
            489  ATP2A3; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 3 [KO:K05853] [EC:3.6.3.8]
            488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:3.6.3.8]
            6786  STIM1; stromal interaction molecule 1 [KO:K16059]
            57620  STIM2; stromal interaction molecule 2 [KO:K18196]
            84876  ORAI1; ORAI calcium release-activated calcium modulator 1 [KO:K16056]
            80228  ORAI2; ORAI calcium release-activated calcium modulator 2 [KO:K16057]
            93129  ORAI3; ORAI calcium release-activated calcium modulator 3 [KO:K16058]
            775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]
            776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]
            778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]
            779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]
            773  CACNA1A; calcium voltage-gated channel subunit alpha1 A [KO:K04344]
            774  CACNA1B; calcium voltage-gated channel subunit alpha1 B [KO:K04849]
            777  CACNA1E; calcium voltage-gated channel subunit alpha1 E [KO:K04852]
            8913  CACNA1G; calcium voltage-gated channel subunit alpha1 G [KO:K04854]
            8912  CACNA1H; calcium voltage-gated channel subunit alpha1 H [KO:K04855]
            8911  CACNA1I; calcium voltage-gated channel subunit alpha1 I [KO:K04856]
            1139  CHRNA7; cholinergic receptor nicotinic alpha 7 subunit [KO:K04809]
            5023  P2RX1; purinergic receptor P2X 1 [KO:K05215]
            22953  P2RX2; purinergic receptor P2X 2 [KO:K05216]
            5024  P2RX3; purinergic receptor P2X 3 [KO:K05217]
            5025  P2RX4; purinergic receptor P2X 4 [KO:K05218]
            5026  P2RX5; purinergic receptor P2X 5 [KO:K05219]
            5027  P2RX7; purinergic receptor P2X 7 [KO:K05220]
            9127  P2RX6; purinergic receptor P2X 6 [KO:K05221]
            2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]
            2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]
            2905  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]
            2906  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]
            6261  RYR1; ryanodine receptor 1 [KO:K04961]
            6262  RYR2; ryanodine receptor 2 [KO:K04962]
            6263  RYR3; ryanodine receptor 3 [KO:K04963]
            10800  CYSLTR1; cysteinyl leukotriene receptor 1 [KO:K04322]
            57105  CYSLTR2; cysteinyl leukotriene receptor 2 [KO:K04323]
            1129  CHRM2; cholinergic receptor muscarinic 2 [KO:K04130]
            148  ADRA1A; adrenoceptor alpha 1A [KO:K04135]
            147  ADRA1B; adrenoceptor alpha 1B [KO:K04136]
            146  ADRA1D; adrenoceptor alpha 1D [KO:K04137]
            185  AGTR1; angiotensin II receptor type 1 [KO:K04166]
            1909  EDNRA; endothelin receptor type A [KO:K04197]
            1910  EDNRB; endothelin receptor type B [KO:K04198]
            2149  F2R; coagulation factor II thrombin receptor [KO:K03914]
            2911  GRM1; glutamate receptor, metabotropic 1 [KO:K04603]
            2915  GRM5; glutamate receptor, metabotropic 5 [KO:K04604]
            2925  GRPR; gastrin releasing peptide receptor [KO:K04169]
            3269  HRH1; histamine receptor H1 [KO:K04149]
            3356  HTR2A; 5-hydroxytryptamine receptor 2A [KO:K04157]
            3357  HTR2B; 5-hydroxytryptamine receptor 2B [KO:K04157]
            3358  HTR2C; 5-hydroxytryptamine receptor 2C [KO:K04157]
            3973  LHCGR; luteinizing hormone/choriogonadotropin receptor [KO:K04248]
            4923  NTSR1; neurotensin receptor 1 (high affinity) [KO:K04211]
            5021  OXTR; oxytocin receptor [KO:K04229]
            552  AVPR1A; arginine vasopressin receptor 1A [KO:K04226]
            553  AVPR1B; arginine vasopressin receptor 1B [KO:K04227]
            56413  LTB4R2; leukotriene B4 receptor 2 [KO:K04297]
            5724  PTAFR; platelet activating factor receptor [KO:K04279]
            5731  PTGER1; prostaglandin E receptor 1 [KO:K04258]
            5733  PTGER3; prostaglandin E receptor 3 [KO:K04260]
            5737  PTGFR; prostaglandin F receptor [KO:K04262]
            623  BDKRB1; bradykinin receptor B1 [KO:K03915]
            624  BDKRB2; bradykinin receptor B2 [KO:K03916]
            6869  TACR1; tachykinin receptor 1 [KO:K04222]
            6865  TACR2; tachykinin receptor 2 [KO:K04223]
            6870  TACR3; tachykinin receptor 3 [KO:K04224]
            6915  TBXA2R; thromboxane A2 receptor [KO:K04264]
            7201  TRHR; thyrotropin releasing hormone receptor [KO:K04282]
            886  CCKAR; cholecystokinin A receptor [KO:K04194]
            887  CCKBR; cholecystokinin B receptor [KO:K04195]
            1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
            2064  ERBB2; erb-b2 receptor tyrosine kinase 2 [KO:K05083] [EC:2.7.10.1]
            2065  ERBB3; erb-b2 receptor tyrosine kinase 3 [KO:K05084] [EC:2.7.10.1]
            2066  ERBB4; erb-b2 receptor tyrosine kinase 4 [KO:K05085] [EC:2.7.10.1]
            5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
            5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]
            2776  GNAQ; G protein subunit alpha q [KO:K04634]
            2767  GNA11; G protein subunit alpha 11 [KO:K04635]
            9630  GNA14; G protein subunit alpha 14 [KO:K04636]
            2769  GNA15; G protein subunit alpha 15 [KO:K04637]
            102723407  putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8; K06856 immunoglobulin heavy chain [KO:K06856]
            5333  PLCD1; phospholipase C delta 1 [KO:K05857] [EC:3.1.4.11]
            113026  PLCD3; phospholipase C delta 3 [KO:K05857] [EC:3.1.4.11]
            84812  PLCD4; phospholipase C delta 4 [KO:K05857] [EC:3.1.4.11]
            23236  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]
            5330  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]
            5331  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]
            5332  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]
            5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]
            5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]
            51196  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]
            89869  PLCZ1; phospholipase C zeta 1 [KO:K05861] [EC:3.1.4.11]
            3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
            3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
            3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
            952  CD38; CD38 molecule [KO:K01242] [EC:2.4.99.20 3.2.2.6]
            8877  SPHK1; sphingosine kinase 1 [KO:K04718] [EC:2.7.1.91]
            56848  SPHK2; sphingosine kinase 2 [KO:K04718] [EC:2.7.1.91]
            7416  VDAC1; voltage dependent anion channel 1 [KO:K05862]
            7417  VDAC2; voltage dependent anion channel 2 [KO:K15040]
            7419  VDAC3; voltage dependent anion channel 3 [KO:K15041]
            291  SLC25A4; solute carrier family 25 member 4 [KO:K05863]
            292  SLC25A5; solute carrier family 25 member 5 [KO:K05863]
            293  SLC25A6; solute carrier family 25 member 6 [KO:K05863]
            83447  SLC25A31; solute carrier family 25 member 31 [KO:K05863]
            10105  PPIF; peptidylprolyl isomerase F [KO:K09565] [EC:5.2.1.8]
            7134  TNNC1; troponin C1, slow skeletal and cardiac type [KO:K05865]
            7125  TNNC2; troponin C2, fast skeletal type [KO:K12042]
            810  CALML3; calmodulin like 3 [KO:K02183]
            805  CALM2; calmodulin 2 (phosphorylase kinase, delta) [KO:K02183]
            808  CALM3; calmodulin 3 (phosphorylase kinase, delta) [KO:K02183]
            801  CALM1; calmodulin 1 (phosphorylase kinase, delta) [KO:K02183]
            163688  CALML6; calmodulin like 6 [KO:K02183]
            51806  CALML5; calmodulin like 5 [KO:K02183]
            5260  PHKG1; phosphorylase kinase gamma subunit 1 [KO:K00871] [EC:2.7.11.19]
            5261  PHKG2; phosphorylase kinase gamma subunit 2 [KO:K00871] [EC:2.7.11.19]
            5257  PHKB; phosphorylase kinase, beta [KO:K07190]
            5256  PHKA2; phosphorylase kinase, alpha 2 (liver) [KO:K07190]
            5255  PHKA1; phosphorylase kinase, alpha 1 (muscle) [KO:K07190]
            4638  MYLK; myosin light chain kinase [KO:K00907] [EC:2.7.11.18]
            85366  MYLK2; myosin light chain kinase 2 [KO:K00907] [EC:2.7.11.18]
            91807  MYLK3; myosin light chain kinase 3 [KO:K00907] [EC:2.7.11.18]
            340156  MYLK4; myosin light chain kinase family member 4 [KO:K00907] [EC:2.7.11.18]
            815  CAMK2A; calcium/calmodulin-dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]
            817  CAMK2D; calcium/calmodulin-dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]
            816  CAMK2B; calcium/calmodulin-dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]
            818  CAMK2G; calcium/calmodulin-dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]
            814  CAMK4; calcium/calmodulin-dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]
            5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]
            5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]
            5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]
            5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]
            5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]
            4842  NOS1; nitric oxide synthase 1 [KO:K13240] [EC:1.14.13.39]
            4843  NOS2; nitric oxide synthase 2 [KO:K13241] [EC:1.14.13.39]
            4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]
            5136  PDE1A; phosphodiesterase 1A [KO:K13755] [EC:3.1.4.17]
            5153  PDE1B; phosphodiesterase 1B [KO:K13755] [EC:3.1.4.17]
            5137  PDE1C; phosphodiesterase 1C [KO:K13755] [EC:3.1.4.17]
            2185  PTK2B; protein tyrosine kinase 2 beta [KO:K05871] [EC:2.7.10.2]
            3707  ITPKB; inositol-trisphosphate 3-kinase B [KO:K00911] [EC:2.7.1.127]
            3706  ITPKA; inositol-trisphosphate 3-kinase A [KO:K00911] [EC:2.7.1.127]
            80271  ITPKC; inositol-trisphosphate 3-kinase C [KO:K00911] [EC:2.7.1.127]
            5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
            5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
            5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
COMPOUND    C00002  ATP
            C00004  NADH
            C00076  Calcium cation
            C00165  Diacylglycerol
            C00575  3',5'-Cyclic AMP
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C01330  Sodium cation
            C06124  Sphingosine 1-phosphate
            C13050  Cyclic ADP-ribose
            C13051  Nicotinic acid adenine dinucleotide phosphate
REFERENCE   PMID:12838335
  AUTHORS   Berridge MJ, Bootman MD, Roderick HL.
  TITLE     Calcium signalling: dynamics, homeostasis and remodelling.
  JOURNAL   Nat Rev Mol Cell Biol 4:517-29 (2003)
REFERENCE   PMID:11413485
  AUTHORS   Berridge MJ, Lipp P, Bootman MD.
  TITLE     The versatility and universality of calcium signalling.
  JOURNAL   Nat Rev Mol Cell Biol 1:11-21 (2000)
REFERENCE   PMID:15111104
  AUTHORS   Wang MC, Dolphin A, Kitmitto A.
  TITLE     L-type voltage-gated calcium channels: understanding function through structure.
  JOURNAL   FEBS Lett 564:245-50 (2004)
REFERENCE   PMID:11299192
  AUTHORS   Ferrier GR, Howlett SE.
  TITLE     Cardiac excitation-contraction coupling: role of membrane potential in regulation of contraction.
  JOURNAL   Am J Physiol Heart Circ Physiol 280:H1928-44 (2001)
REFERENCE   PMID:11698232
  AUTHORS   Keef KD, Hume JR, Zhong J.
  TITLE     Regulation of cardiac and smooth muscle Ca(2+) channels (Ca(V)1.2a,b) by protein kinases.
  JOURNAL   Am J Physiol Cell Physiol 281:C1743-56 (2001)
REFERENCE   PMID:8125957
  AUTHORS   Hell JW, Appleyard SM, Yokoyama CT, Warner C, Catterall WA.
  TITLE     Differential phosphorylation of two size forms of the N-type calcium channel alpha 1 subunit which have different COOH termini.
  JOURNAL   J Biol Chem 269:7390-6 (1994)
REFERENCE   PMID:15000521
  AUTHORS   Yunker AM.
  TITLE     Modulation and pharmacology of low voltage-activated (&quot;T-Type&quot;) calcium channels.
  JOURNAL   J Bioenerg Biomembr 35:577-98 (2003)
REFERENCE   PMID:9149541
  AUTHORS   Yakel JL.
  TITLE     Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription.
  JOURNAL   Trends Pharmacol Sci 18:124-34 (1997)
REFERENCE   PMID:10997573
  AUTHORS   Fukunaga K, Miyamoto E.
  TITLE     A working model of CaM kinase II activity in hippocampal long-term potentiation and memory.
  JOURNAL   Neurosci Res 38:3-17 (2000)
REFERENCE   PMID:9235901
  AUTHORS   Della Rocca GJ, van Biesen T, Daaka Y, Luttrell DK, Luttrell LM, Lefkowitz RJ.
  TITLE     Ras-dependent mitogen-activated protein kinase activation by G protein-coupled receptors. Convergence of Gi- and Gq-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase.
  JOURNAL   J Biol Chem 272:19125-32 (1997)
REFERENCE   PMID:7861177
  AUTHORS   Furuichi T, Mikoshiba K.
  TITLE     Inositol 1, 4, 5-trisphosphate receptor-mediated Ca2+ signaling in the brain.
  JOURNAL   J Neurochem 64:953-60 (1995)
REFERENCE   PMID:14572802
  AUTHORS   Bruce JI, Straub SV, Yule DI.
  TITLE     Crosstalk between cAMP and Ca2+ signaling in non-excitable cells.
  JOURNAL   Cell Calcium 34:431-44 (2003)
REFERENCE   PMID:10331643
  AUTHORS   Lee HC, Munshi C, Graeff R.
  TITLE     Structures and activities of cyclic ADP-ribose, NAADP and their metabolic enzymes.
  JOURNAL   Mol Cell Biochem 193:89-98 (1999)
REFERENCE   PMID:11080247
  AUTHORS   Crompton M.
  TITLE     Mitochondrial intermembrane junctional complexes and their role in cell death.
  JOURNAL   J Physiol 529 Pt 1:11-21 (2000)
REFERENCE   PMID:10508738
  AUTHORS   Grewal SS, York RD, Stork PJ.
  TITLE     Extracellular-signal-regulated kinase signalling in neurons.
  JOURNAL   Curr Opin Neurobiol 9:544-53 (1999)
REFERENCE   PMID:12972622
  AUTHORS   Trushin SA, Pennington KN, Carmona EM, Asin S, Savoy DN, Billadeau DD, Paya CV.
  TITLE     Protein kinase Calpha (PKCalpha) acts upstream of PKCtheta to activate IkappaB kinase and NF-kappaB in T lymphocytes.
  JOURNAL   Mol Cell Biol 23:7068-81 (2003)
REFERENCE   PMID:14517314
  AUTHORS   Hutchins JR, Dikovskaya D, Clarke PR.
  TITLE     Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II.
  JOURNAL   Mol Biol Cell 14:4003-14 (2003)
REFERENCE   PMID:21338471
  AUTHORS   Tornquist K
  TITLE     Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells.
  JOURNAL   Acta Physiol (Oxf) 204:151-7 (2012)
REFERENCE   PMID:22129055
  AUTHORS   Feske S
  TITLE     Immunodeficiency due to defects in store-operated calcium entry.
  JOURNAL   Ann N Y Acad Sci 1238:74-90 (2011)
REFERENCE   PMID:22002090
  AUTHORS   Giachini FR, Lima VV, Hannan JL, Carneiro FS, Webb RC, Tostes RC
  TITLE     STIM1/Orai1-mediated store-operated Ca2+ entry: the tip of the iceberg.
  JOURNAL   Braz J Med Biol Res 44:1080-7 (2011)
REFERENCE   PMID:19172794
  AUTHORS   Baba Y, Kurosaki T
  TITLE     [Regulation of store-operated calcium entry by STIM1].
  JOURNAL   Seikagaku 80:1123-8 (2008)
KO_PATHWAY  ko04020
///
ENTRY       hsa04024                    Pathway
NAME        cAMP signaling pathway - Homo sapiens (human)
DESCRIPTION cAMP is one of the most common and universal second messengers, and its formation is promoted by adenylyl cyclase (AC) activation after ligation of G protein-coupled receptors (GPCRs) by ligands including hormones, neurotransmitters, and other signaling molecules. cAMP regulates pivotal physiologic processes including metabolism, secretion, calcium homeostasis, muscle contraction, cell fate, and gene transcription. cAMP acts directly on three main targets: protein kinase A (PKA), the exchange protein activated by cAMP (Epac), and cyclic nucleotide-gated ion channels (CNGCs). PKA modulates, via phosphorylation, a number of cellular substrates, including transcription factors, ion channels, transporters, exchangers, intracellular Ca2+ -handling proteins, and the contractile machinery. Epac proteins function as guanine nucleotide exchange factors (GEFs) for both Rap1 and Rap2. Various effector proteins, including adaptor proteins implicated in modulation of the actin cytoskeleton, regulators of G proteins of the Rho family, and phospholipases, relay signaling downstream from Rap.
CLASS       Environmental Information Processing; Signal transduction
PATHWAY_MAP hsa04024  cAMP signaling pathway
MODULE      hsa_M00695  cAMP signaling [PATH:hsa04024]
DBLINKS     GO: 0019933
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        2488  FSHB; follicle stimulating hormone beta subunit [KO:K05250]
            153  ADRB1; adrenoceptor beta 1 [KO:K04141]
            1812  DRD1; dopamine receptor D1 [KO:K04144]
            1816  DRD5; dopamine receptor D5 [KO:K05840]
            135  ADORA2A; adenosine A2a receptor [KO:K04266]
            3360  HTR4; 5-hydroxytryptamine receptor 4 [KO:K04160]
            3362  HTR6; 5-hydroxytryptamine receptor 6 [KO:K04162]
            5732  PTGER2; prostaglandin E receptor 2 [KO:K04259]
            117  ADCYAP1R1; ADCYAP receptor type I [KO:K04587]
            7434  VIPR2; vasoactive intestinal peptide receptor 2 [KO:K04590]
            7253  TSHR; thyroid stimulating hormone receptor [KO:K04249]
            4158  MC2R; melanocortin 2 receptor [KO:K04200]
            2740  GLP1R; glucagon like peptide 1 receptor [KO:K04581]
            2696  GIPR; gastric inhibitory polypeptide receptor [KO:K04580]
            139760  GPR119; G protein-coupled receptor 119 [KO:K08424]
            2492  FSHR; follicle stimulating hormone receptor [KO:K04247]
            4881  NPR1; natriuretic peptide receptor 1 [KO:K12323] [EC:4.6.1.2]
            2778  GNAS; GNAS complex locus [KO:K04632]
            4852  NPY; neuropeptide Y [KO:K05232]
            51738  GHRL; ghrelin/obestatin prepropeptide [KO:K05254]
            154  ADRB2; adrenoceptor beta 2 [KO:K04142]
            3350  HTR1A; 5-hydroxytryptamine receptor 1A [KO:K04153]
            3351  HTR1B; 5-hydroxytryptamine receptor 1B [KO:K04153]
            3352  HTR1D; 5-hydroxytryptamine receptor 1D [KO:K04153]
            3354  HTR1E; 5-hydroxytryptamine receptor 1E [KO:K04153]
            3355  HTR1F; 5-hydroxytryptamine receptor 1F [KO:K04153]
            1128  CHRM1; cholinergic receptor muscarinic 1 [KO:K04129]
            1129  CHRM2; cholinergic receptor muscarinic 2 [KO:K04130]
            1813  DRD2; dopamine receptor D2 [KO:K04145]
            2550  GABBR1; gamma-aminobutyric acid type B receptor subunit 1 [KO:K04615]
            9568  GABBR2; gamma-aminobutyric acid type B receptor subunit 2 [KO:K04615]
            134  ADORA1; adenosine A1 receptor [KO:K04265]
            1909  EDNRA; endothelin receptor type A [KO:K04197]
            4886  NPY1R; neuropeptide Y receptor Y1 [KO:K04204]
            6751  SSTR1; somatostatin receptor 1 [KO:K04217]
            6752  SSTR2; somatostatin receptor 2 [KO:K04218]
            6755  SSTR5; somatostatin receptor 5 [KO:K04221]
            27198  HCAR1; hydroxycarboxylic acid receptor 1 [KO:K08401]
            338442  HCAR2; hydroxycarboxylic acid receptor 2 [KO:K08402]
            8843  HCAR3; hydroxycarboxylic acid receptor 3 [KO:K08402]
            2867  FFAR2; free fatty acid receptor 2 [KO:K04328]
            56670  SUCNR1; succinate receptor 1 [KO:K10042]
            5733  PTGER3; prostaglandin E receptor 3 [KO:K04260]
            5021  OXTR; oxytocin receptor [KO:K04229]
            2693  GHSR; growth hormone secretagogue receptor [KO:K04284]
            2770  GNAI1; G protein subunit alpha i1 [KO:K04630]
            2773  GNAI3; G protein subunit alpha i3 [KO:K04630]
            2771  GNAI2; G protein subunit alpha i2 [KO:K04630]
            107  ADCY1; adenylate cyclase 1 (brain) [KO:K08041] [EC:4.6.1.1]
            108  ADCY2; adenylate cyclase 2 (brain) [KO:K08042] [EC:4.6.1.1]
            109  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]
            196883  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]
            111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]
            112  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]
            113  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]
            114  ADCY8; adenylate cyclase 8 (brain) [KO:K08048] [EC:4.6.1.1]
            115  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]
            55811  ADCY10; adenylate cyclase 10 (soluble) [KO:K11265] [EC:4.6.1.1]
            610  HCN2; hyperpolarization activated cyclic nucleotide gated potassium channel 2 [KO:K04955]
            10021  HCN4; hyperpolarization activated cyclic nucleotide gated potassium channel 4 [KO:K04957]
            1259  CNGA1; cyclic nucleotide gated channel alpha 1 [KO:K04948]
            1260  CNGA2; cyclic nucleotide gated channel alpha 2 [KO:K04949]
            1261  CNGA3; cyclic nucleotide gated channel alpha 3 [KO:K04950]
            1262  CNGA4; cyclic nucleotide gated channel alpha 4 [KO:K04951]
            1258  CNGB1; cyclic nucleotide gated channel beta 1 [KO:K04952]
            54714  CNGB3; cyclic nucleotide gated channel beta 3 [KO:K04953]
            810  CALML3; calmodulin like 3 [KO:K02183]
            805  CALM2; calmodulin 2 (phosphorylase kinase, delta) [KO:K02183]
            808  CALM3; calmodulin 3 (phosphorylase kinase, delta) [KO:K02183]
            801  CALM1; calmodulin 1 (phosphorylase kinase, delta) [KO:K02183]
            163688  CALML6; calmodulin like 6 [KO:K02183]
            51806  CALML5; calmodulin like 5 [KO:K02183]
            815  CAMK2A; calcium/calmodulin-dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]
            817  CAMK2D; calcium/calmodulin-dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]
            816  CAMK2B; calcium/calmodulin-dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]
            818  CAMK2G; calcium/calmodulin-dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]
            814  CAMK4; calcium/calmodulin-dependent protein kinase IV [KO:K05869] [EC:2.7.11.17]
            10257  ABCC4; ATP binding cassette subfamily C member 4 [KO:K05673]
            10411  RAPGEF3; Rap guanine nucleotide exchange factor 3 [KO:K08014]
            11069  RAPGEF4; Rap guanine nucleotide exchange factor 4 [KO:K04351]
            6237  RRAS; related RAS viral (r-ras) oncogene homolog [KO:K07829]
            22800  RRAS2; related RAS viral (r-ras) oncogene homolog 2 [KO:K07830]
            5337  PLD1; phospholipase D1 [KO:K01115] [EC:3.1.4.4]
            5338  PLD2; phospholipase D2 [KO:K01115] [EC:3.1.4.4]
            51196  PLCE1; phospholipase C epsilon 1 [KO:K05860] [EC:3.1.4.11]
            5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            5906  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]
            5908  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]
            7074  TIAM1; T-cell lymphoma invasion and metastasis 1 [KO:K05731]
            10451  VAV3; vav guanine nucleotide exchange factor 3 [KO:K05730]
            7409  VAV1; vav guanine nucleotide exchange factor 1 [KO:K05730]
            7410  VAV2; vav guanine nucleotide exchange factor 2 [KO:K05730]
            5879  RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [KO:K04392]
            5880  RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) [KO:K07860]
            5881  RAC3; ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) [KO:K07861]
            5058  PAK1; p21 protein (Cdc42/Rac)-activated kinase 1 [KO:K04409] [EC:2.7.11.1]
            64411  ARAP3; ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 [KO:K12490]
            387  RHOA; ras homolog family member A [KO:K04513]
            4301  MLLT4; myeloid/lymphoid or mixed-lineage leukemia [KO:K05702]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            207  AKT1; v-akt murine thymoma viral oncogene homolog 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; v-akt murine thymoma viral oncogene homolog 2 [KO:K04456] [EC:2.7.11.1]
            10000  AKT3; v-akt murine thymoma viral oncogene homolog 3 [KO:K04456] [EC:2.7.11.1]
            673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]
            5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
            5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
            5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
            5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
            84152  PPP1R1B; protein phosphatase 1 regulatory inhibitor subunit 1B [KO:K15494]
            5499  PPP1CA; protein phosphatase 1 catalytic subunit alpha [KO:K06269] [EC:3.1.3.16]
            5500  PPP1CB; protein phosphatase 1 catalytic subunit beta [KO:K06269] [EC:3.1.3.16]
            5501  PPP1CC; protein phosphatase 1 catalytic subunit gamma [KO:K06269] [EC:3.1.3.16]
            1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]
            10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]
            90993  CREB3L1; cAMP responsive element binding protein 3-like 1 [KO:K09048]
            64764  CREB3L2; cAMP responsive element binding protein 3-like 2 [KO:K09048]
            84699  CREB3L3; cAMP responsive element binding protein 3-like 3 [KO:K09048]
            148327  CREB3L4; cAMP responsive element binding protein 3-like 4 [KO:K09048]
            9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]
            1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]
            2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]
            627  BDNF; brain-derived neurotrophic factor [KO:K04355]
            2353  FOS; FBJ murine osteosarcoma viral oncogene homolog [KO:K04379]
            3725  JUN; jun proto-oncogene [KO:K04448]
            2737  GLI3; GLI family zinc finger 3 [KO:K06230]
            2735  GLI1; GLI family zinc finger 1 [KO:K16797]
            5727  PTCH1; patched 1 [KO:K06225]
            64399  HHIP; hedgehog interacting protein [KO:K06231]
            4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]
            4790  NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [KO:K02580]
            5970  RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A [KO:K04735]
            6662  SOX9; SRY-box 9 [KO:K18435]
            268  AMH; anti-Mullerian hormone [KO:K04665]
            5465  PPARA; peroxisome proliferator activated receptor alpha [KO:K07294]
            8310  ACOX3; acyl-CoA oxidase 3, pristanoyl [KO:K00232] [EC:1.3.3.6]
            51  ACOX1; acyl-CoA oxidase 1, palmitoyl [KO:K00232] [EC:1.3.3.6]
            4772  NFATC1; nuclear factor of activated T-cells 1 [KO:K04446]
            2149  F2R; coagulation factor II thrombin receptor [KO:K03914]
            572  BAD; BCL2 associated agonist of cell death [KO:K02158]
            3991  LIPE; lipase E, hormone sensitive type [KO:K07188] [EC:3.1.1.79]
            6093  ROCK1; Rho associated coiled-coil containing protein kinase 1 [KO:K04514] [EC:2.7.11.1]
            9475  ROCK2; Rho associated coiled-coil containing protein kinase 2 [KO:K17388] [EC:2.7.11.1]
            4659  PPP1R12A; protein phosphatase 1 regulatory subunit 12A [KO:K06270]
            10398  MYL9; myosin light chain 9 [KO:K12755]
            7137  TNNI3; troponin I3, cardiac type [KO:K12044]
            5350  PLN; phospholamban [KO:K05852]
            6262  RYR2; ryanodine receptor 2 [KO:K04962]
            2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]
            2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]
            2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]
            2905  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]
            2906  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]
            116443  GRIN3A; glutamate ionotropic receptor NMDA type subunit 3A [KO:K05213]
            116444  GRIN3B; glutamate ionotropic receptor NMDA type subunit 3B [KO:K05214]
            2890  GRIA1; glutamate ionotropic receptor AMPA type subunit 1 [KO:K05197]
            2891  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]
            2892  GRIA3; glutamate ionotropic receptor AMPA type subunit 3 [KO:K05199]
            2893  GRIA4; glutamate ionotropic receptor AMPA type subunit 4 [KO:K05200]
            1080  CFTR; cystic fibrosis transmembrane conductance regulator [KO:K05031] [EC:3.6.3.49]
            476  ATP1A1; ATPase Na+/K+ transporting subunit alpha 1 [KO:K01539] [EC:3.6.3.9]
            477  ATP1A2; ATPase Na+/K+ transporting subunit alpha 2 [KO:K01539] [EC:3.6.3.9]
            478  ATP1A3; ATPase Na+/K+ transporting subunit alpha 3 [KO:K01539] [EC:3.6.3.9]
            480  ATP1A4; ATPase Na+/K+ transporting subunit alpha 4 [KO:K01539] [EC:3.6.3.9]
            23439  ATP1B4; ATPase Na+/K+ transporting family member beta 4 [KO:K01540]
            481  ATP1B1; ATPase Na+/K+ transporting subunit beta 1 [KO:K01540]
            482  ATP1B2; ATPase Na+/K+ transporting subunit beta 2 [KO:K01540]
            483  ATP1B3; ATPase Na+/K+ transporting subunit beta 3 [KO:K01540]
            486  FXYD2; FXYD domain containing ion transport regulator 2 [KO:K01538]
            5348  FXYD1; FXYD domain containing ion transport regulator 1 [KO:K13360]
            6548  SLC9A1; solute carrier family 9 member A1 [KO:K05742]
            84876  ORAI1; ORAI calcium release-activated calcium modulator 1 [KO:K16056]
            490  ATP2B1; ATPase plasma membrane Ca2+ transporting 1 [KO:K05850] [EC:3.6.3.8]
            492  ATP2B3; ATPase plasma membrane Ca2+ transporting 3 [KO:K05850] [EC:3.6.3.8]
            493  ATP2B4; ATPase plasma membrane Ca2+ transporting 4 [KO:K05850] [EC:3.6.3.8]
            491  ATP2B2; ATPase plasma membrane Ca2+ transporting 2 [KO:K05850] [EC:3.6.3.8]
            775  CACNA1C; calcium voltage-gated channel subunit alpha1 C [KO:K04850]
            776  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]
            778  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]
            779  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]
            5139  PDE3A; phosphodiesterase 3A [KO:K19021] [EC:3.1.4.17]
            5140  PDE3B; phosphodiesterase 3B [KO:K13296] [EC:3.1.4.17]
            5141  PDE4A; phosphodiesterase 4A [KO:K13293] [EC:3.1.4.53]
            5142  PDE4B; phosphodiesterase 4B [KO:K13293] [EC:3.1.4.53]
            5143  PDE4C; phosphodiesterase 4C [KO:K13293] [EC:3.1.4.53]
            5144  PDE4D; phosphodiesterase 4D [KO:K13293] [EC:3.1.4.53]
            488  ATP2A2; ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 [KO:K05853] [EC:3.6.3.8]
COMPOUND    C00020  AMP
            C00042  Succinate
            C00076  Calcium cation
            C00080  H+
            C00165  Diacylglycerol
            C00186  (S)-Lactate
            C00212  Adenosine
            C00238  Potassium cation
            C00288  HCO3-
            C00334  4-Aminobutanoate
            C00416  Phosphatidate
            C00547  L-Noradrenaline
            C00575  3',5'-Cyclic AMP
            C00584  Prostaglandin E2
            C00698  Cl-
            C00746  Oxytocin
            C00780  Serotonin
            C00788  L-Adrenaline
            C01089  (R)-3-Hydroxybutanoate
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C01312  Prostaglandin I2
            C01330  Sodium cation
            C01996  Acetylcholine
            C02017  Corticotropin
            C03758  Dopamine
            C15906  Glucose-dependent insulinotropic peptide
            C15949  Neuropeptide Y
            C16003  Atrial natriuretic peptide
            C16010  Endothelin-1
            C16012  Endothelin-2
            C16013  Endothelin-3
            C16021  Somatostatin-28
            C16022  Somatostatin-14
            C16048  Glucagon-like peptide 1
            C16088  Pituitary adenylate cyclase-activating peptide-38
            C16089  Pituitary adenylate cyclase-activating peptide-27
            C16119  Vasoactive intestinal peptide
            C18182  Thyroid stimulating hormone
            C20792  Oleoylethanolamide
            C20793  3-Hydroxyoctanoate
REFERENCE   PMID:11493633
  AUTHORS   Fimia GM, Sassone-Corsi P
  TITLE     Cyclic AMP signalling.
  JOURNAL   J Cell Sci 114:1971-2 (2001)
REFERENCE   PMID:18323530
  AUTHORS   Serezani CH, Ballinger MN, Aronoff DM, Peters-Golden M
  TITLE     Cyclic AMP: master regulator of innate immune cell function.
  JOURNAL   Am J Respir Cell Mol Biol 39:127-32 (2008)
REFERENCE   PMID:24281338
  AUTHORS   Oldenburger A, Maarsingh H, Schmidt M
  TITLE     Multiple facets of cAMP signalling and physiological impact: cAMP compartmentalization in the lung.
  JOURNAL   Pharmaceuticals (Basel) 5:1291-331 (2012)
REFERENCE   PMID:24613710
  AUTHORS   Ahuja M, Jha A, Maleth J, Park S, Muallem S
  TITLE     cAMP and Ca signaling in secretory epithelia: Crosstalk and synergism.
  JOURNAL   Cell Calcium 55:385-393 (2014)
REFERENCE   PMID:22082266
  AUTHORS   Shirshev SV
  TITLE     Role of Epac proteins in mechanisms of cAMP-dependent immunoregulation.
  JOURNAL   Biochemistry (Mosc) 76:981-98 (2011)
REFERENCE   PMID:18176800
  AUTHORS   Roscioni SS, Elzinga CR, Schmidt M
  TITLE     Epac: effectors and biological functions.
  JOURNAL   Naunyn Schmiedebergs Arch Pharmacol 377:345-57 (2008)
REFERENCE   PMID:24450633
  AUTHORS   Roberts OL, Dart C
  TITLE     cAMP signalling in the vasculature: the role of Epac (exchange protein directly activated by cAMP).
  JOURNAL   Biochem Soc Trans 42:89-97 (2014)
REFERENCE   PMID:16765984
  AUTHORS   Schaub MC, Hefti MA, Zaugg M
  TITLE     Integration of calcium with the signaling network in cardiac myocytes.
  JOURNAL   J Mol Cell Cardiol 41:183-214 (2006)
REFERENCE   PMID:19874988
  AUTHORS   Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J
  TITLE     The sympathetic nervous system in heart failure physiology, pathophysiology, and  clinical implications.
  JOURNAL   J Am Coll Cardiol 54:1747-62 (2009)
REFERENCE   PMID:15142747
  AUTHORS   Saucerman JJ, McCulloch AD
  TITLE     Mechanistic systems models of cell signaling networks: a case study of myocyte adrenergic regulation.
  JOURNAL   Prog Biophys Mol Biol 85:261-78 (2004)
REFERENCE   PMID:21212391
  AUTHORS   Yang JH, Saucerman JJ
  TITLE     Computational models reduce complexity and accelerate insight into cardiac signaling networks.
  JOURNAL   Circ Res 108:85-97 (2011)
REFERENCE   PMID:22022314
  AUTHORS   Taggart P, Boyett MR, Logantha S, Lambiase PD
  TITLE     Anger, emotion, and arrhythmias: from brain to heart.
  JOURNAL   Front Physiol 2:67 (2011)
REFERENCE   PMID:21852968
  AUTHORS   Bozzi Y, Dunleavy M, Henshall DC
  TITLE     Cell signaling underlying epileptic behavior.
  JOURNAL   Front Behav Neurosci 5:45 (2011)
REFERENCE   PMID:10880354
  AUTHORS   Lizcano JM, Morrice N, Cohen P
  TITLE     Regulation of BAD by cAMP-dependent protein kinase is mediated via phosphorylation of a novel site, Ser155.
  JOURNAL   Biochem J 349:547-57 (2000)
REFERENCE   PMID:21744067
  AUTHORS   Gerlo S, Kooijman R, Beck IM, Kolmus K, Spooren A, Haegeman G
  TITLE     Cyclic AMP: a selective modulator of NF-kappaB action.
  JOURNAL   Cell Mol Life Sci 68:3823-41 (2011)
REFERENCE   PMID:7688165
  AUTHORS   Lauder JM
  TITLE     Neurotransmitters as growth regulatory signals: role of receptors and second messengers.
  JOURNAL   Trends Neurosci 16:233-40 (1993)
REFERENCE   PMID:17077866
  AUTHORS   Voglis G, Tavernarakis N
  TITLE     The role of synaptic ion channels in synaptic plasticity.
  JOURNAL   EMBO Rep 7:1104-10 (2006)
REFERENCE   PMID:21346730
  AUTHORS   Altarejos JY, Montminy M
  TITLE     CREB and the CRTC co-activators: sensors for hormonal and metabolic signals.
  JOURNAL   Nat Rev Mol Cell Biol 12:141-51 (2011)
REFERENCE   PMID:24062645
  AUTHORS   Bozzi Y, Borrelli E
  TITLE     The role of dopamine signaling in epileptogenesis.
  JOURNAL   Front Cell Neurosci 7:157 (2013)
REFERENCE   PMID:14715909
  AUTHORS   Ceulemans H, Bollen M
  TITLE     Functional diversity of protein phosphatase-1, a cellular economizer and reset button.
  JOURNAL   Physiol Rev 84:1-39 (2004)
REFERENCE   PMID:16571352
  AUTHORS   Lipinski RJ, Gipp JJ, Zhang J, Doles JD, Bushman W
  TITLE     Unique and complimentary activities of the Gli transcription factors in Hedgehog  signaling.
  JOURNAL   Exp Cell Res 312:1925-38 (2006)
REFERENCE   PMID:21693691
  AUTHORS   Lasala C, Schteingart HF, Arouche N, Bedecarras P, Grinspon RP, Picard JY, Josso N, di Clemente N, Rey RA
  TITLE     SOX9 and SF1 are involved in cyclic AMP-mediated upregulation of anti-Mullerian gene expression in the testicular prepubertal Sertoli cell line SMAT1.
  JOURNAL   Am J Physiol Endocrinol Metab 301:E539-47 (2011)
REFERENCE   PMID:19460777
  AUTHORS   Rosenkranz AC, Rauch BH, Freidel K, Schror K
  TITLE     Regulation of protease-activated receptor-1 by vasodilatory prostaglandins via NFAT.
  JOURNAL   Cardiovasc Res 83:778-84 (2009)
REFERENCE   PMID:11117527
  AUTHORS   Lazennec G, Canaple L, Saugy D, Wahli W
  TITLE     Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.
  JOURNAL   Mol Endocrinol 14:1962-75 (2000)
REFERENCE   PMID:16460276
  AUTHORS   Murthy KS
  TITLE     Signaling for contraction and relaxation in smooth muscle of the gut.
  JOURNAL   Annu Rev Physiol 68:345-74 (2006)
REFERENCE   PMID:18064650
  AUTHORS   Birukova AA, Zagranichnaya T, Alekseeva E, Bokoch GM, Birukov KG
  TITLE     Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection.
  JOURNAL   J Cell Physiol 215:715-24 (2008)
REFERENCE   PMID:9204709
  AUTHORS   Houslay MD, Milligan G
  TITLE     Tailoring cAMP-signalling responses through isoform multiplicity.
  JOURNAL   Trends Biochem Sci 22:217-24 (1997)
KO_PATHWAY  ko04024
///
ENTRY       hsa04150                    Pathway
NAME        mTOR signaling pathway - Homo sapiens (human)
CLASS       Environmental Information Processing; Signal transduction
PATHWAY_MAP hsa04150  mTOR signaling pathway
DISEASE     H00539  PTEN hamartoma tumor syndrome (PHTS)
            H00666  Peutz-Jeghers syndrome
            H00896  Lymphangioleiomyomatosis (LAM)
            H00915  Tuberous sclerosis complex (TSC)
            H01112  Polyhydramnios, megalencephaly, and symptomatic epilepsy
            H01251  Focal cortical dysplasia of Taylor
DRUG        D00595  Buformin (USAN/INN)
            D00753  Sirolimus (JAN/USAN/INN)
            D00944  Metformin hydrochloride (JP17/USP)
            D02206  Buformin hydrochloride (JP17)
            D02714  Everolimus (JAN/USAN/INN)
            D03647  Dapiclermin (USAN/INN)
            D04966  Metformin (USAN/INN)
            D05393  Pegsunercept (USAN)
            D06068  Temsirolimus (JAN/USAN/INN)
            D06272  Sorafenib tosilate (JAN)
            D06409  Bevacizumab (genetical recombination) (JAN)
            D08351  Phenformin (BAN)
            D08352  Phenformin hydrochloride
            D08524  Sorafenib (USAN/INN)
            D08900  Ridaforolimus (JAN/USAN)
            D10076  Olcorolimus (USAN)
            D10635  Gedatolisib (USAN/INN)
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        3630  INS; insulin [KO:K04526]
            3479  IGF1; insulin like growth factor 1 [KO:K05459]
            3667  IRS1; insulin receptor substrate 1 [KO:K16172]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K00922] [EC:2.7.1.153]
            5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.67 3.1.3.48 3.1.3.16]
            5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
            207  AKT1; v-akt murine thymoma viral oncogene homolog 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; v-akt murine thymoma viral oncogene homolog 2 [KO:K04456] [EC:2.7.11.1]
            10000  AKT3; v-akt murine thymoma viral oncogene homolog 3 [KO:K04456] [EC:2.7.11.1]
            84335  AKT1S1; AKT1 substrate 1 (proline rich) [KO:K16184]
            7248  TSC1; tuberous sclerosis 1 [KO:K07206]
            7249  TSC2; tuberous sclerosis 2 [KO:K07207]
            6009  RHEB; Ras homolog enriched in brain [KO:K07208]
            64223  MLST8; MTOR associated protein, LST8 homolog [KO:K08266]
            10670  RRAGA; Ras related GTP binding A [KO:K16185]
            10325  RRAGB; Ras related GTP binding B [KO:K16185]
            64121  RRAGC; Ras related GTP binding C [KO:K16186]
            58528  RRAGD; Ras related GTP binding D [KO:K16186]
            2475  MTOR; mechanistic target of rapamycin [KO:K07203] [EC:2.7.11.1]
            57521  RPTOR; regulatory associated protein of MTOR, complex 1 [KO:K07204]
            253260  RICTOR; RPTOR independent companion of MTOR, complex 2 [KO:K08267]
            3091  HIF1A; hypoxia inducible factor 1 alpha subunit [KO:K08268]
            7422  VEGFA; vascular endothelial growth factor A [KO:K05448]
            6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]
            6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]
            1975  EIF4B; eukaryotic translation initiation factor 4B [KO:K03258]
            6194  RPS6; ribosomal protein S6 [KO:K02991]
            1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]
            1977  EIF4E; eukaryotic translation initiation factor 4E [KO:K03259]
            9470  EIF4E2; eukaryotic translation initiation factor 4E family member 2 [KO:K03259]
            253314  EIF4E1B; eukaryotic translation initiation factor 4E family member 1B [KO:K03259]
            25989  ULK3; unc-51 like kinase 3 [KO:K08269] [EC:2.7.11.1]
            8408  ULK1; unc-51 like autophagy activating kinase 1 [KO:K08269] [EC:2.7.11.1]
            9706  ULK2; unc-51 like autophagy activating kinase 2 [KO:K08269] [EC:2.7.11.1]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            6197  RPS6KA3; ribosomal protein S6 kinase A3 [KO:K04373] [EC:2.7.11.1]
            6195  RPS6KA1; ribosomal protein S6 kinase A1 [KO:K04373] [EC:2.7.11.1]
            6196  RPS6KA2; ribosomal protein S6 kinase A2 [KO:K04373] [EC:2.7.11.1]
            27330  RPS6KA6; ribosomal protein S6 kinase A6 [KO:K04373] [EC:2.7.11.1]
            54541  DDIT4; DNA damage inducible transcript 4 [KO:K08270]
            7124  TNF; tumor necrosis factor [KO:K03156]
            3551  IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta [KO:K07209] [EC:2.7.11.10]
            6794  STK11; serine/threonine kinase 11 [KO:K07298]
            92335  STRADA; STE20-related kinase adaptor alpha [KO:K08271]
            51719  CAB39; calcium binding protein 39 [KO:K08272]
            81617  CAB39L; calcium binding protein 39 like [KO:K08272]
            5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.11]
            5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.11]
            673  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]
            5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
            5579  PRKCB; protein kinase C beta [KO:K19662] [EC:2.7.11.13]
            5582  PRKCG; protein kinase C gamma [KO:K19663] [EC:2.7.11.13]
COMPOUND    C00020  AMP
            C04677  1-(5'-Phosphoribosyl)-5-amino-4-imidazolecarboxamide
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
            C15181  Wortmannin
            C15182  Temsirolimus
            C15183  AP 23573
            C15195  LY 294002
            D00753  Sirolimus (JAN/USAN/INN)
            D00944  Metformin hydrochloride (JP17/USP)
            D02714  Everolimus (JAN/USAN/INN)
REFERENCE   PMID:15624019
  AUTHORS   Inoki K, Corradetti MN, Guan KL.
  TITLE     Dysregulation of the TSC-mTOR pathway in human disease.
  JOURNAL   Nat Genet 37:19-24 (2005)
REFERENCE   PMID:16404421
  AUTHORS   Petroulakis E, Mamane Y, Le Bacquer O, Shahbazian D, Sonenberg N.
  TITLE     mTOR signaling: implications for cancer and anticancer therapy.
  JOURNAL   Br J Cancer 94:195-9 (2006)
REFERENCE   PMID:16226444
  AUTHORS   Sarbassov dos D, Ali SM, Sabatini DM.
  TITLE     Growing roles for the mTOR pathway.
  JOURNAL   Curr Opin Cell Biol 17:596-603 (2005)
REFERENCE   PMID:16469695
  AUTHORS   Wullschleger S, Loewith R, Hall MN.
  TITLE     TOR signaling in growth and metabolism.
  JOURNAL   Cell 124:471-84 (2006)
REFERENCE   PMID:16288290
  AUTHORS   Plas DR, Thompson CB.
  TITLE     Akt-dependent transformation: there is more to growth than just surviving.
  JOURNAL   Oncogene 24:7435-42 (2005)
REFERENCE   PMID:16452501
  AUTHORS   Levine AJ, Feng Z, Mak TW, You H, Jin S
  TITLE     Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways.
  JOURNAL   Genes Dev 20:267-75 (2006)
REFERENCE   PMID:15509864
  AUTHORS   Hardie DG.
  TITLE     The AMP-activated protein kinase pathway--new players upstream and downstream.
  JOURNAL   J Cell Sci 117:5479-87 (2004)
REFERENCE   PMID:15780593
  AUTHORS   Hardie DG.
  TITLE     New roles for the LKB1--&gt;AMPK pathway.
  JOURNAL   Curr Opin Cell Biol 17:167-73 (2005)
REFERENCE   PMID:16288294
  AUTHORS   Astrinidis A, Henske EP.
  TITLE     Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease.
  JOURNAL   Oncogene 24:7475-81 (2005)
REFERENCE   PMID:15928081
  AUTHORS   Feng Z, Zhang H, Levine AJ, Jin S.
  TITLE     The coordinate regulation of the p53 and mTOR pathways in cells.
  JOURNAL   Proc Natl Acad Sci U S A 102:8204-9 (2005)
REFERENCE   PMID:16288292
  AUTHORS   Altomare DA, Testa JR.
  TITLE     Perturbations of the AKT signaling pathway in human cancer.
  JOURNAL   Oncogene 24:7455-64 (2005)
REFERENCE   PMID:16244323
  AUTHORS   Kwiatkowski DJ, Manning BD.
  TITLE     Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways.
  JOURNAL   Hum Mol Genet 14 Spec No. 2:R251-8 (2005)
REFERENCE   PMID:16002336
  AUTHORS   Guertin DA, Sabatini DM.
  TITLE     An expanding role for mTOR in cancer.
  JOURNAL   Trends Mol Med 11:353-61 (2005)
REFERENCE   PMID:14684182
  AUTHORS   Tokunaga C, Yoshino K, Yonezawa K.
  TITLE     mTOR integrates amino acid- and energy-sensing pathways.
  JOURNAL   Biochem Biophys Res Commun 313:443-6 (2004)
REFERENCE   PMID:16341064
  AUTHORS   Hennessy BT, Smith DL, Ram PT, Lu Y, Mills GB.
  TITLE     Exploiting the PI3K/AKT pathway for cancer drug discovery.
  JOURNAL   Nat Rev Drug Discov 4:988-1004 (2005)
REFERENCE   PMID:15681023
  AUTHORS   Luo Z, Saha AK, Xiang X, Ruderman NB.
  TITLE     AMPK, the metabolic syndrome and cancer.
  JOURNAL   Trends Pharmacol Sci 26:69-76 (2005)
REFERENCE   PMID:15659337
  AUTHORS   Tee AR, Blenis J.
  TITLE     mTOR, translational control and human disease.
  JOURNAL   Semin Cell Dev Biol 16:29-37 (2005)
REFERENCE   PMID:15276465
  AUTHORS   Proud CG.
  TITLE     Ras, PI3-kinase and mTOR signaling in cardiac hypertrophy.
  JOURNAL   Cardiovasc Res 63:403-13 (2004)
REFERENCE   PMID:15988001
  AUTHORS   Sofer A, Lei K, Johannessen CM, Ellisen LW.
  TITLE     Regulation of mTOR and cell growth in response to energy stress by REDD1.
  JOURNAL   Mol Cell Biol 25:5834-45 (2005)
REFERENCE   PMID:16099218
  AUTHORS   Deretic V.
  TITLE     Autophagy in innate and adaptive immunity.
  JOURNAL   Trends Immunol 26:523-8 (2005)
REFERENCE   PMID:15928708
  AUTHORS   Lum JJ, DeBerardinis RJ, Thompson CB.
  TITLE     Autophagy in metazoans: cell survival in the land of plenty.
  JOURNAL   Nat Rev Mol Cell Biol 6:439-48 (2005)
REFERENCE   PMID:15261137
  AUTHORS   Brugarolas J, Kaelin WG Jr.
  TITLE     Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes.
  JOURNAL   Cancer Cell 6:7-10 (2004)
REFERENCE   PMID:16109716
  AUTHORS   Hui L, Rodrik V, Pielak RM, Knirr S, Zheng Y, Foster DA.
  TITLE     mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells.
  JOURNAL   J Biol Chem 280:35829-35 (2005)
REFERENCE   PMID:19100909
  AUTHORS   Hall MN
  TITLE     mTOR-what does it do?
  JOURNAL   Transplant Proc 40:S5-8 (2008)
REFERENCE   PMID:18598780
  AUTHORS   Rosner M, Hanneder M, Siegel N, Valli A, Fuchs C, Hengstschlager M
  TITLE     The mTOR pathway and its role in human genetic diseases.
  JOURNAL   Mutat Res 659:284-92 (2008)
REFERENCE   PMID:18604198
  AUTHORS   Kim E, Goraksha-Hicks P, Li L, Neufeld TP, Guan KL
  TITLE     Regulation of TORC1 by Rag GTPases in nutrient response.
  JOURNAL   Nat Cell Biol 10:935-45 (2008)
REFERENCE   PMID:18497260
  AUTHORS   Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L, Sabatini DM
  TITLE     The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1.
  JOURNAL   Science 320:1496-501 (2008)
REFERENCE   PMID:19963289
  AUTHORS   Hoeffer CA, Klann E
  TITLE     mTOR signaling: at the crossroads of plasticity, memory and disease.
  JOURNAL   Trends Neurosci 33:67-75 (2010)
KO_PATHWAY  ko04150
///
ENTRY       hsa04151                    Pathway
NAME        PI3K-Akt signaling pathway - Homo sapiens (human)
DESCRIPTION The phosphatidylinositol 3' -kinase(PI3K)-Akt signaling pathway is activated by many types of cellular stimuli or toxic insults and regulates fundamental cellular functions such as transcription, translation, proliferation, growth, and survival. The binding of growth factors to their receptor tyrosine kinase (RTK) or G protein-coupled receptors (GPCR) stimulates class Ia and Ib PI3K isoforms, respectively. PI3K catalyzes the production of phosphatidylinositol-3,4,5-triphosphate (PIP3) at the cell membrane. PIP3 in turn serves as a second messenger that helps to activate Akt. Once active, Akt can control key cellular processes by phosphorylating substrates involved in apoptosis, protein synthesis, metabolism, and cell cycle.
CLASS       Environmental Information Processing; Signal transduction
PATHWAY_MAP hsa04151  PI3K-Akt signaling pathway
MODULE      hsa_M00676  PI3K-Akt signaling [PATH:hsa04151]
DISEASE     H01338  Myosclerosis
            H01340  Bethlem myopathy
            H01341  Collagen VI myopathy
            H01370  SHORT syndrome
            H01387  Activated PI3K-delta syndrome (APDS)
            H01388  Hyperprolactinemia
            H01511  Mast-cell leukemia
DRUG        D08503  Toceranib (USAN)
            D08544  Toceranib phosphate (USAN)
            D10189  Pictilisib (USAN)
            D10224  Golvatinib (USAN)
            D10229  Masitinib (INN)
            D10242  Lipegfilgrastim (USAN)
            D10354  Dupilumab (USAN)
            D10365  Gandotinib (USAN)
            D10381  Afuresertib (USAN)
            D10382  Afuresertib hydrochloride (USAN)
            D10395  Nesvacumab (USAN)
            D10465  Golvatinib tartrate (USAN)
            D10635  Gedatolisib (USAN/INN)
            D10641  Ipatasertib (USAN/INN)
DBLINKS     GO: 0043491
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        1950  EGF; epidermal growth factor [KO:K04357]
            2246  FGF1; fibroblast growth factor 1 [KO:K18496]
            2247  FGF2; fibroblast growth factor 2 [KO:K18497]
            2248  FGF3; fibroblast growth factor 3 [KO:K04358]
            2249  FGF4; fibroblast growth factor 4 [KO:K04358]
            8822  FGF17; fibroblast growth factor 17 [KO:K04358]
            2251  FGF6; fibroblast growth factor 6 [KO:K04358]
            2252  FGF7; fibroblast growth factor 7 [KO:K04358]
            2253  FGF8; fibroblast growth factor 8 [KO:K04358]
            2254  FGF9; fibroblast growth factor 9 [KO:K04358]
            2255  FGF10; fibroblast growth factor 10 [KO:K04358]
            2256  FGF11; fibroblast growth factor 11 [KO:K04358]
            2257  FGF12; fibroblast growth factor 12 [KO:K04358]
            2258  FGF13; fibroblast growth factor 13 [KO:K04358]
            2259  FGF14; fibroblast growth factor 14 [KO:K04358]
            8823  FGF16; fibroblast growth factor 16 [KO:K04358]
            2250  FGF5; fibroblast growth factor 5 [KO:K04358]
            8817  FGF18; fibroblast growth factor 18 [KO:K04358]
            9965  FGF19; fibroblast growth factor 19 [KO:K04358]
            26281  FGF20; fibroblast growth factor 20 [KO:K04358]
            26291  FGF21; fibroblast growth factor 21 [KO:K04358]
            27006  FGF22; fibroblast growth factor 22 [KO:K04358]
            8074  FGF23; fibroblast growth factor 23 [KO:K04358]
            4803  NGF; nerve growth factor [KO:K02582]
            3630  INS; insulin [KO:K04526]
            3479  IGF1; insulin like growth factor 1 [KO:K05459]
            5154  PDGFA; platelet derived growth factor subunit A [KO:K04359]
            5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]
            56034  PDGFC; platelet derived growth factor C [KO:K05450]
            80310  PDGFD; platelet derived growth factor D [KO:K05450]
            1435  CSF1; colony stimulating factor 1 [KO:K05453]
            4254  KITLG; KIT ligand [KO:K05461]
            7422  VEGFA; vascular endothelial growth factor A [KO:K05448]
            7423  VEGFB; vascular endothelial growth factor B [KO:K16858]
            5228  PGF; placental growth factor [KO:K16859]
            7424  VEGFC; vascular endothelial growth factor C [KO:K05449]
            2277  FIGF; c-fos induced growth factor (vascular endothelial growth factor D) [KO:K05449]
            3082  HGF; hepatocyte growth factor [KO:K05460]
            284  ANGPT1; angiopoietin 1 [KO:K05465]
            285  ANGPT2; angiopoietin 2 [KO:K05466]
            51378  ANGPT4; angiopoietin 4 [KO:K05467]
            1942  EFNA1; ephrin-A1 [KO:K05462]
            1943  EFNA2; ephrin-A2 [KO:K05462]
            1944  EFNA3; ephrin-A3 [KO:K05462]
            1945  EFNA4; ephrin-A4 [KO:K05462]
            1946  EFNA5; ephrin-A5 [KO:K05462]
            1956  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
            2260  FGFR1; fibroblast growth factor receptor 1 [KO:K04362] [EC:2.7.10.1]
            2263  FGFR2; fibroblast growth factor receptor 2 [KO:K05093] [EC:2.7.10.1]
            2261  FGFR3; fibroblast growth factor receptor 3 [KO:K05094] [EC:2.7.10.1]
            2264  FGFR4; fibroblast growth factor receptor 4 [KO:K05095] [EC:2.7.10.1]
            4804  NGFR; nerve growth factor receptor [KO:K02583]
            3643  INSR; insulin receptor [KO:K04527] [EC:2.7.10.1]
            3480  IGF1R; insulin like growth factor 1 receptor [KO:K05087] [EC:2.7.10.1]
            5156  PDGFRA; platelet derived growth factor receptor alpha [KO:K04363] [EC:2.7.10.1]
            5159  PDGFRB; platelet derived growth factor receptor beta [KO:K05089] [EC:2.7.10.1]
            1436  CSF1R; colony stimulating factor 1 receptor [KO:K05090] [EC:2.7.10.1]
            3815  KIT; KIT proto-oncogene receptor tyrosine kinase [KO:K05091] [EC:2.7.10.1]
            2321  FLT1; fms related tyrosine kinase 1 [KO:K05096] [EC:2.7.10.1]
            2324  FLT4; fms related tyrosine kinase 4 [KO:K05097] [EC:2.7.10.1]
            3791  KDR; kinase insert domain receptor [KO:K05098] [EC:2.7.10.1]
            4233  MET; MET proto-oncogene, receptor tyrosine kinase [KO:K05099] [EC:2.7.10.1]
            7010  TEK; TEK receptor tyrosine kinase [KO:K05121] [EC:2.7.10.1]
            1969  EPHA2; EPH receptor A2 [KO:K05103] [EC:2.7.10.1]
            2885  GRB2; growth factor receptor bound protein 2 [KO:K04364]
            6654  SOS1; SOS Ras/Rac guanine nucleotide exchange factor 1 [KO:K03099]
            6655  SOS2; SOS Ras/Rho guanine nucleotide exchange factor 2 [KO:K03099]
            3265  HRAS; Harvey rat sarcoma viral oncogene homolog [KO:K02833]
            3845  KRAS; Kirsten rat sarcoma viral oncogene homolog [KO:K07827]
            4893  NRAS; neuroblastoma RAS viral (v-ras) oncogene homolog [KO:K07828]
            5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
            5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            3667  IRS1; insulin receptor substrate 1 [KO:K16172]
            7097  TLR2; toll like receptor 2 [KO:K10159]
            7099  TLR4; toll like receptor 4 [KO:K10160]
            5879  RAC1; ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) [KO:K04392]
            102723407  putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8; K06856 immunoglobulin heavy chain [KO:K06856]
            6850  SYK; spleen tyrosine kinase [KO:K05855] [EC:2.7.10.2]
            930  CD19; CD19 molecule [KO:K06465]
            118788  PIK3AP1; phosphoinositide-3-kinase adaptor protein 1 [KO:K12230]
            2688  GH1; growth hormone 1 [KO:K05438]
            2689  GH2; growth hormone 2 [KO:K05438]
            1442  CSH1; chorionic somatomammotropin hormone 1 [KO:K05438]
            1443  CSH2; chorionic somatomammotropin hormone 2 [KO:K05438]
            5617  PRL; prolactin [KO:K05439]
            5008  OSM; oncostatin M [KO:K05418]
            3558  IL2; interleukin 2 [KO:K05429]
            3562  IL3; interleukin 3 [KO:K04736]
            3569  IL6; interleukin 6 [KO:K05405]
            3565  IL4; interleukin 4 [KO:K05430]
            3574  IL7; interleukin 7 [KO:K05431]
            3439  IFNA1; interferon, alpha 1 [KO:K05414]
            3440  IFNA2; interferon, alpha 2 [KO:K05414]
            3441  IFNA4; interferon, alpha 4 [KO:K05414]
            3442  IFNA5; interferon alpha 5 [KO:K05414]
            3443  IFNA6; interferon alpha 6 [KO:K05414]
            3444  IFNA7; interferon, alpha 7 [KO:K05414]
            3445  IFNA8; interferon alpha 8 [KO:K05414]
            3446  IFNA10; interferon, alpha 10 [KO:K05414]
            3447  IFNA13; interferon, alpha 13 [KO:K05414]
            3448  IFNA14; interferon alpha 14 [KO:K05414]
            3449  IFNA16; interferon, alpha 16 [KO:K05414]
            3451  IFNA17; interferon, alpha 17 [KO:K05414]
            3452  IFNA21; interferon, alpha 21 [KO:K05414]
            3456  IFNB1; interferon beta 1 [KO:K05415]
            2056  EPO; erythropoietin [KO:K05437]
            1440  CSF3; colony stimulating factor 3 [KO:K05423]
            2690  GHR; growth hormone receptor [KO:K05080]
            5618  PRLR; prolactin receptor [KO:K05081]
            9180  OSMR; oncostatin M receptor [KO:K05057]
            3559  IL2RA; interleukin 2 receptor subunit alpha [KO:K05068]
            3560  IL2RB; interleukin 2 receptor subunit beta [KO:K05069]
            3561  IL2RG; interleukin 2 receptor subunit gamma [KO:K05070]
            3563  IL3RA; interleukin 3 receptor subunit alpha [KO:K04737]
            3570  IL6R; interleukin 6 receptor [KO:K05055]
            3566  IL4R; interleukin 4 receptor [KO:K05071]
            3575  IL7R; interleukin 7 receptor [KO:K05072]
            3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]
            3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]
            2057  EPOR; erythropoietin receptor [KO:K05079]
            1441  CSF3R; colony stimulating factor 3 receptor [KO:K05061]
            3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]
            3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]
            3718  JAK3; Janus kinase 3 [KO:K11218] [EC:2.7.10.2]
            1277  COL1A1; collagen type I alpha 1 [KO:K06236]
            1278  COL1A2; collagen type I alpha 2 [KO:K06236]
            1280  COL2A1; collagen type II alpha 1 [KO:K19719]
            1284  COL4A2; collagen type IV alpha 2 [KO:K06237]
            1286  COL4A4; collagen type IV alpha 4 [KO:K06237]
            1288  COL4A6; collagen type IV alpha 6 [KO:K06237]
            1282  COL4A1; collagen type IV alpha 1 [KO:K06237]
            1287  COL4A5; collagen type IV alpha 5 [KO:K06237]
            1285  COL4A3; collagen type IV alpha 3 [KO:K06237]
            1291  COL6A1; collagen type VI alpha 1 [KO:K06238]
            1292  COL6A2; collagen type VI alpha 2 [KO:K06238]
            1293  COL6A3; collagen type VI alpha 3 [KO:K06238]
            131873  COL6A6; collagen type VI alpha 6 [KO:K06238]
            256076  COL6A5; collagen type VI alpha 5 [KO:K06238]
            1297  COL9A1; collagen type IX alpha 1 [KO:K08131]
            1298  COL9A2; collagen type IX alpha 2 [KO:K08131]
            1299  COL9A3; collagen type IX alpha 3 [KO:K08131]
            284217  LAMA1; laminin subunit alpha 1 [KO:K05637]
            3908  LAMA2; laminin subunit alpha 2 [KO:K05637]
            3909  LAMA3; laminin subunit alpha 3 [KO:K06240]
            3911  LAMA5; laminin subunit alpha 5 [KO:K06240]
            3910  LAMA4; laminin subunit alpha 4 [KO:K06241]
            3912  LAMB1; laminin subunit beta 1 [KO:K05636]
            3913  LAMB2; laminin subunit beta 2 [KO:K06243]
            3914  LAMB3; laminin subunit beta 3 [KO:K06244]
            22798  LAMB4; laminin subunit beta 4 [KO:K06245]
            3915  LAMC1; laminin subunit gamma 1 [KO:K05635]
            3918  LAMC2; laminin subunit gamma 2 [KO:K06246]
            10319  LAMC3; laminin subunit gamma 3 [KO:K06247]
            1101  CHAD; chondroadherin [KO:K06248]
            5649  RELN; reelin [KO:K06249] [EC:3.4.21.-]
            7057  THBS1; thrombospondin 1 [KO:K16857]
            1311  COMP; cartilage oligomeric matrix protein [KO:K04659]
            7058  THBS2; thrombospondin 2 [KO:K04659]
            7059  THBS3; thrombospondin 3 [KO:K04659]
            7060  THBS4; thrombospondin 4 [KO:K04659]
            2335  FN1; fibronectin 1 [KO:K05717]
            6696  SPP1; secreted phosphoprotein 1 [KO:K06250]
            7448  VTN; vitronectin [KO:K06251]
            3371  TNC; tenascin C [KO:K06252]
            63923  TNN; tenascin N [KO:K06252]
            7143  TNR; tenascin R [KO:K06252]
            7148  TNXB; tenascin XB [KO:K06252]
            7450  VWF; von Willebrand factor [KO:K03900]
            3381  IBSP; integrin binding sialoprotein [KO:K06253]
            3672  ITGA1; integrin subunit alpha 1 [KO:K06480]
            3673  ITGA2; integrin subunit alpha 2 [KO:K06481]
            3674  ITGA2B; integrin subunit alpha 2b [KO:K06476]
            3675  ITGA3; integrin subunit alpha 3 [KO:K06482]
            3676  ITGA4; integrin subunit alpha 4 [KO:K06483]
            3678  ITGA5; integrin subunit alpha 5 [KO:K06484]
            3655  ITGA6; integrin subunit alpha 6 [KO:K06485]
            3679  ITGA7; integrin subunit alpha 7 [KO:K06583]
            8516  ITGA8; integrin subunit alpha 8 [KO:K06584]
            3680  ITGA9; integrin subunit alpha 9 [KO:K06585]
            8515  ITGA10; integrin subunit alpha 10 [KO:K06586]
            22801  ITGA11; integrin subunit alpha 11 [KO:K06587]
            3685  ITGAV; integrin subunit alpha V [KO:K06487]
            3688  ITGB1; integrin subunit beta 1 [KO:K05719]
            3690  ITGB3; integrin subunit beta 3 [KO:K06493]
            3691  ITGB4; integrin subunit beta 4 [KO:K06525]
            3693  ITGB5; integrin subunit beta 5 [KO:K06588]
            3694  ITGB6; integrin subunit beta 6 [KO:K06589]
            3695  ITGB7; integrin subunit beta 7 [KO:K06590]
            3696  ITGB8; integrin subunit beta 8 [KO:K06591]
            5747  PTK2; protein tyrosine kinase 2 [KO:K05725] [EC:2.7.10.2]
            2149  F2R; coagulation factor II thrombin receptor [KO:K03914]
            1128  CHRM1; cholinergic receptor muscarinic 1 [KO:K04129]
            1129  CHRM2; cholinergic receptor muscarinic 2 [KO:K04130]
            1902  LPAR1; lysophosphatidic acid receptor 1 [KO:K04289]
            9170  LPAR2; lysophosphatidic acid receptor 2 [KO:K04291]
            23566  LPAR3; lysophosphatidic acid receptor 3 [KO:K04294]
            2846  LPAR4; lysophosphatidic acid receptor 4 [KO:K04275]
            57121  LPAR5; lysophosphatidic acid receptor 5 [KO:K08390]
            10161  LPAR6; lysophosphatidic acid receptor 6 [KO:K04273]
            2782  GNB1; G protein subunit beta 1 [KO:K04536]
            2783  GNB2; G protein subunit beta 2 [KO:K04537]
            2784  GNB3; G protein subunit beta 3 [KO:K07825]
            59345  GNB4; G protein subunit beta 4 [KO:K04538]
            10681  GNB5; G protein subunit beta 5 [KO:K04539]
            54331  GNG2; G protein subunit gamma 2 [KO:K07826]
            2785  GNG3; G protein subunit gamma 3 [KO:K04540]
            2786  GNG4; G protein subunit gamma 4 [KO:K04541]
            2787  GNG5; G protein subunit gamma 5 [KO:K04542]
            2788  GNG7; G protein subunit gamma 7 [KO:K04543]
            94235  GNG8; G protein subunit gamma 8 [KO:K04544]
            2790  GNG10; G protein subunit gamma 10 [KO:K04545]
            2791  GNG11; G protein subunit gamma 11 [KO:K04546]
            55970  GNG12; G protein subunit gamma 12 [KO:K04347]
            51764  GNG13; G protein subunit gamma 13 [KO:K04547]
            2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]
            2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]
            5170  PDPK1; 3-phosphoinositide dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
            6794  STK11; serine/threonine kinase 11 [KO:K07298]
            5562  PRKAA1; protein kinase AMP-activated catalytic subunit alpha 1 [KO:K07198] [EC:2.7.11.11]
            5563  PRKAA2; protein kinase AMP-activated catalytic subunit alpha 2 [KO:K07198] [EC:2.7.11.11]
            54541  DDIT4; DNA damage inducible transcript 4 [KO:K08270]
            7248  TSC1; tuberous sclerosis 1 [KO:K07206]
            7249  TSC2; tuberous sclerosis 2 [KO:K07207]
            6009  RHEB; Ras homolog enriched in brain [KO:K07208]
            64223  MLST8; MTOR associated protein, LST8 homolog [KO:K08266]
            2475  MTOR; mechanistic target of rapamycin [KO:K07203] [EC:2.7.11.1]
            57521  RPTOR; regulatory associated protein of MTOR, complex 1 [KO:K07204]
            1978  EIF4EBP1; eukaryotic translation initiation factor 4E binding protein 1 [KO:K07205]
            1977  EIF4E; eukaryotic translation initiation factor 4E [KO:K03259]
            9470  EIF4E2; eukaryotic translation initiation factor 4E family member 2 [KO:K03259]
            253314  EIF4E1B; eukaryotic translation initiation factor 4E family member 1B [KO:K03259]
            6198  RPS6KB1; ribosomal protein S6 kinase B1 [KO:K04688] [EC:2.7.11.1]
            6199  RPS6KB2; ribosomal protein S6 kinase B2 [KO:K04688] [EC:2.7.11.1]
            1975  EIF4B; eukaryotic translation initiation factor 4B [KO:K03258]
            6194  RPS6; ribosomal protein S6 [KO:K02991]
            5578  PRKCA; protein kinase C alpha [KO:K02677] [EC:2.7.11.13]
            5585  PKN1; protein kinase N1 [KO:K06071] [EC:2.7.11.13]
            29941  PKN3; protein kinase N3 [KO:K06071] [EC:2.7.11.13]
            5586  PKN2; protein kinase N2 [KO:K06071] [EC:2.7.11.13]
            6446  SGK1; serum/glucocorticoid regulated kinase 1 [KO:K13302] [EC:2.7.11.1]
            10110  SGK2; serum/glucocorticoid regulated kinase 2 [KO:K13303] [EC:2.7.11.1]
            23678  SGK3; serum/glucocorticoid regulated kinase family member 3 [KO:K13304] [EC:2.7.11.1]
            100533105  C8orf44-SGK3; C8orf44-SGK3 readthrough [KO:K13304] [EC:2.7.11.1]
            207  AKT1; v-akt murine thymoma viral oncogene homolog 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; v-akt murine thymoma viral oncogene homolog 2 [KO:K04456] [EC:2.7.11.1]
            10000  AKT3; v-akt murine thymoma viral oncogene homolog 3 [KO:K04456] [EC:2.7.11.1]
            5728  PTEN; phosphatase and tensin homolog [KO:K01110] [EC:3.1.3.67 3.1.3.48 3.1.3.16]
            117145  THEM4; thioesterase superfamily member 4 [KO:K16339]
            5515  PPP2CA; protein phosphatase 2 catalytic subunit alpha [KO:K04382] [EC:3.1.3.16]
            5516  PPP2CB; protein phosphatase 2 catalytic subunit beta [KO:K04382] [EC:3.1.3.16]
            5519  PPP2R1B; protein phosphatase 2 regulatory subunit A, beta [KO:K03456]
            5518  PPP2R1A; protein phosphatase 2 regulatory subunit A, alpha [KO:K03456]
            5520  PPP2R2A; protein phosphatase 2 regulatory subunit B, alpha [KO:K04354]
            5521  PPP2R2B; protein phosphatase 2 regulatory subunit B, beta [KO:K04354]
            5522  PPP2R2C; protein phosphatase 2 regulatory subunit B, gamma [KO:K04354]
            55844  PPP2R2D; protein phosphatase 2 regulatory subunit B, delta [KO:K04354]
            28227  PPP2R3B; protein phosphatase 2 regulatory subunit B'', beta [KO:K11583]
            55012  PPP2R3C; protein phosphatase 2 regulatory subunit B'', gamma [KO:K11583]
            5523  PPP2R3A; protein phosphatase 2 regulatory subunit B'', alpha [KO:K11583]
            5526  PPP2R5B; protein phosphatase 2 regulatory subunit B', beta [KO:K11584]
            5527  PPP2R5C; protein phosphatase 2 regulatory subunit B', gamma [KO:K11584]
            5528  PPP2R5D; protein phosphatase 2 regulatory subunit B', delta [KO:K11584]
            5529  PPP2R5E; protein phosphatase 2 regulatory subunit B', epsilon [KO:K11584]
            5525  PPP2R5A; protein phosphatase 2 regulatory subunit B', alpha [KO:K11584]
            3320  HSP90AA1; heat shock protein 90kDa alpha family class A member 1 [KO:K04079]
            3326  HSP90AB1; heat shock protein 90kDa alpha family class B member 1 [KO:K04079]
            7184  HSP90B1; heat shock protein 90kDa beta family member 1 [KO:K09487]
            11140  CDC37; cell division cycle 37 [KO:K09554]
            200186  CRTC2; CREB regulated transcription coactivator 2 [KO:K16333]
            23239  PHLPP1; PH domain and leucine rich repeat protein phosphatase 1 [KO:K16340] [EC:3.1.3.16]
            23035  PHLPP2; PH domain and leucine rich repeat protein phosphatase 2 [KO:K16340] [EC:3.1.3.16]
            8115  TCL1A; T-cell leukemia/lymphoma 1A [KO:K10167]
            9623  TCL1B; T-cell leukemia/lymphoma 1B [KO:K16836]
            4515  MTCP1; mature T-cell proliferation 1 [KO:K16837]
            4846  NOS3; nitric oxide synthase 3 [KO:K13242] [EC:1.14.13.39]
            672  BRCA1; breast cancer 1 [KO:K10605] [EC:2.3.2.27]
            2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
            2998  GYS2; glycogen synthase 2 [KO:K00693] [EC:2.4.1.11]
            2997  GYS1; glycogen synthase 1 [KO:K00693] [EC:2.4.1.11]
            5105  PCK1; phosphoenolpyruvate carboxykinase 1 [KO:K01596] [EC:4.1.1.32]
            5106  PCK2; phosphoenolpyruvate carboxykinase 2, mitochondrial [KO:K01596] [EC:4.1.1.32]
            2538  G6PC; glucose-6-phosphatase catalytic subunit [KO:K01084] [EC:3.1.3.9]
            57818  G6PC2; glucose-6-phosphatase catalytic subunit 2 [KO:K01084] [EC:3.1.3.9]
            92579  G6PC3; glucose 6 phosphatase catalytic subunit 3 [KO:K01084] [EC:3.1.3.9]
            4609  MYC; v-myc avian myelocytomatosis viral oncogene homolog [KO:K04377]
            595  CCND1; cyclin D1 [KO:K04503]
            1026  CDKN1A; cyclin-dependent kinase inhibitor 1A [KO:K06625]
            1027  CDKN1B; cyclin-dependent kinase inhibitor 1B [KO:K06624]
            1017  CDK2; cyclin-dependent kinase 2 [KO:K02206] [EC:2.7.11.22]
            1019  CDK4; cyclin-dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
            1021  CDK6; cyclin-dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
            894  CCND2; cyclin D2 [KO:K10151]
            896  CCND3; cyclin D3 [KO:K10152]
            898  CCNE1; cyclin E1 [KO:K06626]
            9134  CCNE2; cyclin E2 [KO:K06626]
            2309  FOXO3; forkhead box O3 [KO:K09408]
            5934  RBL2; retinoblastoma-like 2 [KO:K16332]
            356  FASLG; Fas ligand [KO:K04389]
            10018  BCL2L11; BCL2 like 11 [KO:K16341]
            7534  YWHAZ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta [KO:K16197]
            7529  YWHAB; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta [KO:K16197]
            10971  YWHAQ; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta [KO:K16197]
            7531  YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon [KO:K06630]
            7533  YWHAH; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta [KO:K16198]
            7532  YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma [KO:K16198]
            572  BAD; BCL2 associated agonist of cell death [KO:K02158]
            598  BCL2L1; BCL2 like 1 [KO:K04570]
            596  BCL2; B-cell CLL/lymphoma 2 [KO:K02161]
            842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]
            1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]
            1386  ATF2; activating transcription factor 2 [KO:K04450]
            468  ATF4; activating transcription factor 4 [KO:K04374]
            10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]
            90993  CREB3L1; cAMP responsive element binding protein 3-like 1 [KO:K09048]
            64764  CREB3L2; cAMP responsive element binding protein 3-like 2 [KO:K09048]
            84699  CREB3L3; cAMP responsive element binding protein 3-like 3 [KO:K09048]
            148327  CREB3L4; cAMP responsive element binding protein 3-like 4 [KO:K09048]
            9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]
            1388  ATF6B; activating transcription factor 6 beta [KO:K09049]
            4170  MCL1; myeloid cell leukemia 1 [KO:K02539]
            6256  RXRA; retinoid X receptor alpha [KO:K08524]
            3164  NR4A1; nuclear receptor subfamily 4 group A member 1 [KO:K04465]
            8517  IKBKG; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma [KO:K07210]
            1147  CHUK; conserved helix-loop-helix ubiquitous kinase [KO:K04467] [EC:2.7.11.10]
            3551  IKBKB; inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta [KO:K07209] [EC:2.7.11.10]
            5970  RELA; v-rel avian reticuloendotheliosis viral oncogene homolog A [KO:K04735]
            4790  NFKB1; nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [KO:K02580]
            4602  MYB; MYB proto-oncogene, transcription factor [KO:K09420]
            4193  MDM2; MDM2 proto-oncogene [KO:K06643] [EC:2.3.2.27]
            7157  TP53; tumor protein p53 [KO:K04451]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K00922] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
COMPOUND    C00020  AMP
            C00533  Nitric oxide
            C04637  1-Phosphatidyl-D-myo-inositol 4,5-bisphosphate
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:16847462
  AUTHORS   Engelman JA, Luo J, Cantley LC
  TITLE     The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism.
  JOURNAL   Nat Rev Genet 7:606-19 (2006)
REFERENCE   PMID:15784165
  AUTHORS   Song G, Ouyang G, Bao S
  TITLE     The activation of Akt/PKB signaling pathway and cell survival.
  JOURNAL   J Cell Mol Med 9:59-71 (2005)
REFERENCE   PMID:21620960
  AUTHORS   Hers I, Vincent EE, Tavare JM
  TITLE     Akt signalling in health and disease.
  JOURNAL   Cell Signal 23:1515-27 (2011)
REFERENCE   PMID:18842113
  AUTHORS   Duronio V
  TITLE     The life of a cell: apoptosis regulation by the PI3K/PKB pathway.
  JOURNAL   Biochem J 415:333-44 (2008)
REFERENCE   PMID:16248975
  AUTHORS   Kim D, Chung J.
  TITLE     Akt: versatile mediator of cell survival and beyond.
  JOURNAL   J Biochem Mol Biol 35:106-15 (2002)
REFERENCE   PMID:12660731
  AUTHORS   Koyasu S
  TITLE     The role of PI3K in immune cells.
  JOURNAL   Nat Immunol 4:313-9 (2003)
REFERENCE   PMID:12669022
  AUTHORS   Okkenhaug K, Vanhaesebroeck B.
  TITLE     PI3K in lymphocyte development, differentiation and activation.
  JOURNAL   Nat Rev Immunol 3:317-30 (2003)
REFERENCE   PMID:15209374
  AUTHORS   Richardson CJ, Schalm SS, Blenis J
  TITLE     PI3-kinase and TOR: PIKTORing cell growth.
  JOURNAL   Semin Cell Dev Biol 15:147-59 (2004)
REFERENCE   PMID:21440011
  AUTHORS   Zhang X, Tang N, Hadden TJ, Rishi AK
  TITLE     Akt, FoxO and regulation of apoptosis.
  JOURNAL   Biochim Biophys Acta 1813:1978-86 (2011)
REFERENCE   PMID:21779440
  AUTHORS   Georgescu MM
  TITLE     PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control.
  JOURNAL   Genes Cancer 1:1170-7 (2010)
REFERENCE   PMID:12531180
  AUTHORS   West KA, Castillo SS, Dennis PA
  TITLE     Activation of the PI3K/Akt pathway and chemotherapeutic resistance.
  JOURNAL   Drug Resist Updat 5:234-48 (2002)
REFERENCE   PMID:9838078
  AUTHORS   Wymann MP, Pirola L
  TITLE     Structure and function of phosphoinositide 3-kinases.
  JOURNAL   Biochim Biophys Acta 1436:127-50 (1998)
REFERENCE   PMID:12048182
  AUTHORS   Moelling K, Schad K, Bosse M, Zimmermann S, Schweneker M
  TITLE     Regulation of Raf-Akt Cross-talk.
  JOURNAL   J Biol Chem 277:31099-106 (2002)
REFERENCE   PMID:16187290
  AUTHORS   Kikani CK, Dong LQ, Liu F
  TITLE     "New"-clear functions of PDK1: beyond a master kinase in the cytosol?
  JOURNAL   J Cell Biochem 96:1157-62 (2005)
REFERENCE   PMID:11357143
  AUTHORS   Blume-Jensen P, Hunter T
  TITLE     Oncogenic kinase signalling.
  JOURNAL   Nature 411:355-65 (2001)
REFERENCE   PMID:15505410
  AUTHORS   Osaki M, Oshimura M, Ito H
  TITLE     PI3K-Akt pathway: its functions and alterations in human cancer.
  JOURNAL   Apoptosis 9:667-76 (2004)
REFERENCE   PMID:17360849
  AUTHORS   Noguchi M, Ropars V, Roumestand C, Suizu F
  TITLE     Proto-oncogene TCL1: more than just a coactivator for Akt.
  JOURNAL   FASEB J 21:2273-84 (2007)
KO_PATHWAY  ko04151
///
